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4νόμωι (γάρ φησι) γλυκὺ καὶ νόμωι πικρόν, νόμωι θερμόν, νόμωι 
ψυχρόν, νόμωι χροιή, ἐτεῆι δὲ ἄτομα καὶ κενόν.
By convention sweet is sweet, bitter is bitter, hot is hot, cold is cold, 
color is color; but in truth there are only atoms and the void.
Democritus, classical philosopher 
Tetralogies of Thrasyllus, ca. 400 BC
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Imagine that it would be possible to take a detailed look at a living system on a molecular scale. Zooming in from an organism to an organ and from organ to cell, 
all the way to the molecules inside a cell, one would be able to see a huge diversity 
of biomolecules, in different shapes and sizes, with each a different task.1 For the cell 
to function as a whole, these different biomolecules need to move around, interact 
with each other and work together. These interactions between biomolecules are an 
essential part of how living systems operate. 
An imbalance in these interactions can have widely varying consequences. Frequently, 
such an imbalance is hardly noticeable, as there are multiple pathways that can fulfil 
the same function, or there is tight regulation. But, sometimes an interaction is crit-
ical, and imbalance can lead to malfunction or death of a cell. When the imbalance 
spreads, the function of a whole organ or organism can be affected, resulting in dis-
ease. One prominent example that starts at such a molecular scale are autoimmune 
diseases, where the body no longer properly differentiates between molecules of 
foreign organisms, such as bacteria or viruses, and its own molecules. Since many 
diseases are associated with changed biomolecular interactions, the study of these 
interactions has become an important part of (bio-)medical research. 
Reliable and sensitive methods to analyse biomolecular interactions have propelled 
a number of applications. For example, research into the fundamental questions of 
how a cell is organized: which molecules interact with each other and when? And 
what effect does such an interaction have? Another example is the development of 
compounds that act as medicine by inhibiting or mimicking interactions to neu-
tralize the imbalance. Additionally, these methods allow diagnosis or study of dis-
eases by testing the presence and activity of specific interaction partners. This thesis 
describes our efforts to further improve the analysis of biomolecular interactions as 
well as applications of the techniques that can be used to study these. 
1.1. Biomolecules
Biomolecules are the molecules used and produced by biological systems. Sugars, 
lipids, nucleic acids and proteins are the most eminent members of this family: 
(macro)molecules that are often found in supramolecular complexes, assembled by 
biological processes. Unlike smaller chemical compounds their biological activity 
depends highly on the dynamic structures and interactions with other biomolecules. 
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Detection of such biomolecules has taken a prominent place in both medicine and 
biomedical research and has improved considerably since the development of a first 
assay for the detection of insulin in blood samples in 1960.2 Clinical laboratories run 
hundreds of analyses a day, detecting a wide range of biomolecules, which aids med-
ical professionals to make diagnoses and to decide on treatments.  Pharmaceutical 
companies analyse hundreds of thousands of chemical compounds, trying to find out 
if and how they interact with specific biomolecules in their search for new drugs. 
Researchers can characterize a biomolecule better than ever, by being able to deter-
mine the exact structure, behaviour and binding partners of a biomolecule, due to a 
range of modern analysis techniques.
1.2. Biomarkers
In the field of biomolecules, biomarkers represent a special case. These are biomol-
ecules that function as indicators of either the presence or risk of developing a dis-
ease (so-called prognostic or predictive markers). Such markers do not necessarily 
have to be directly involved in a disease process, but can also be a by-product. An 
example that has been in use for years is the prostate-specific antigen (PSA) marker: 
abnormal structure of the prostate can release PSA in blood and is thereby an easy 
indicator for the presence and stage of prostate cancer, even though it is not directly 
involved in prostate function or tumour formation.3 
To be successful, a biomarker has to be specific, preferably indicative of only one 
disease. Also, it has to be present in quantities that allow reliable detection. Although 
detection techniques become more and more sensitive, the noise level in biologi-
cal samples often makes highly sensitive detection problematic. Finally, the analysis 
has to be feasible, e.g. by the presence of the biomarker in a blood sample, since a 
biomarker that is not analytically tractable in clinical practice will be of little use. 
Especially useful in this regard are antibodies: they are present in serum, by design 
specific and yet highly similar in structure, which allows the development of a sin-
gle technical assay for a range of biomarkers. These practical properties have led to 
application of antibody biomarkers far outside the field of infectious diseases from 
which they originate. To give just a number of examples, antibodies have been used 
in detection of cancer(s),4 facilitate tracking of various gastro-intestinal or liver dis-
orders5,6 and can be used to predict the onset of psychiatric disorders.7
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The numerous different antibodies that are markers for disease have spurred devel-
opment of many (often automated) assays for detection of antibodies. Especially 
the development of various biosensors is useful for high throughput, multiplex and 
point-of-care applications.8 
1.3. Biosensors
A biosensor is an analysis device or material that uses a biological sensing element, 
coupled to an electronic, optical, acoustic or other sort of physical readout for detec-
tion of biomarkers. These biosensors are being developed for two types of applica-
tions: large-scale, high-throughput laboratory equipment to analyse a multitude of 
samples, and small, portable self-contained devices for point-of-care or home use.9 
Although over time many types of biosensors have been developed, two types dom-
inate practical use today. 
Most portable devices rely on enzyme-mediated detection using an electrochemi-
cal readout. One of the first of such examples was the amperometric glucose sen-
sor, useful for diabetes patients, using a ferricinium-ion to mediate electron transfer 
between immobilised glucose oxidase enzymes and the graphite electrode upon 
oxidation, resulting in a current linear to the glucose concentration in the sample.10 
Modernized versions of this device still make up a majority of the portable biosen-
sors on the market.9
Current laboratory-scale biosensors generally are based on optical readouts. Surface 
Plasmon Resonance (SPR) has pioneered such optical detection based systems. One 
of the first commercial sensors of this class was developed in 1990 and since then 
SPR has become an important enabling technology.11 Allowing not only detection, 
but also real-time tracking and characterization of binding events, a variety of SPR 
biosensors have found use in fundamental research, and pharmaceutical, cosmetic 
and other industries.
Surface Plasmon Resonance
SPR biosensors are based on the well-established physical phenomenon of sur-
face plasmon waves, first described in 1902 when an inhomogeneous spectrum 
of light reflected through a diffraction grating was observed.12 In most biosensors 
this behaviour concerns light that undergoes total internal reflection at an optical 
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interface coated with a thin layer of metal or semiconductor on top of which a sam-
ple is introduced, a setup first described by Kretschmann and Raether.13 With the 
right entrance angle and wavelength, surface plasmons on the metal surface can be 
excited by in-plane polarised light reflecting on this interface, resulting in a reduced 
intensity of the reflected light. The resonant angle at which this occurs depends 
strongly on the refractive index at the interface of the metal surface and a sample. 
Adsorption of biomolecules to the metal surface causes a change in refractive index 
and thereby in the resonant angle. Monitoring changes in this resonant angle and 
plotting this against time in a sensorgram, allows tracking of surface-association or 
-dissociation of biomolecules (Figure 1.1).14,15 By immobilizing a specific target on 
the surface, binding of molecules from solution (the analyte) to the surface-bound 
ligands can be monitored in real-time. After establishing a baseline signal, the sensor 
surface is exposed to the analyte and an associative phase, indicative of complex for-
mation, can be observed. Over time an equilibrium between bound and free analyte 
will be established, observed as a plateau in the sensorgram.  Subsequent incubation 
with buffer allows the dissociation to be observed by a decrease in sensor response. 
This way, both association and dissociation rates and equilibrium binding levels can 
be determined. 
Time
RU
Association
Steady state
Dissociation
Regeneration
Figure 1.1: SPR sensorgram displaying the various analysis stages. From left to right, initial state, 
association of the analyte leading to an increasing resonance angle, steady state when association and 
dissociation of the analyte are in balance, then when the sample is replaced by buffer only dissociation 
takes place resulting in decreasing resonance angle, and finally incubation with a regeneration solution 
which removes the last of the analyte and returns the system to the initial state.
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Due to the specific binding of the analyte on the sensor surface, the analyte is con-
centrated, facilitating detection of very low analyte concentrations. In contrast to 
other common and sensitive readout techniques like fluorescence, this detection 
methodology does not require modification of the analyte with a label like a fluoro-
phore. Depending on analyte and instrument, concentrations as low as 10 pM can 
be detected. However, when desirable, labelling can be used to improve sensitivity 
even further. An example is the use of antibody bioconjugates on superparamagnetic 
beads, which bind the target analyte to increase its mass and allow concentrations 
as low as 300 aM (3 · 10-16 mol/L) to be detected in serum.16 At the same time, analysis 
of the binding kinetics provides a broad operating range for establishing interaction 
parameters. Typical are association rates of 103 – 109 M-1 s-1 and dissociation rates of 
10-5 - 1 s-1, corresponding to interactions with a dissociation constant (K
D
) ranging 
from pM to µM.17 
Another advantage of the surface-bound ligand is the ability to measure interac-
tion properties in non-purified biological samples. While this is rather common for 
systems which perform only detection, there are few systems which combine this 
with the ability to determine (kinetic) interaction parameters. For alternative tech-
niques, such as isothermal calorimetry, it is often crucial that only a single binding 
event is taking place. Especially in the field of biomarkers, this allows characteriza-
tion of binding partners in samples like serum or saliva with no or limited sample 
preparation.
Besides an advantage, the surface is also one of the main weaknesses of the SPR sen-
sor. Surface immobilization introduces a range of possibilities for artefacts, which 
should be carefully controlled by experimental design. Critical reviews of biosen-
sor literature have described a number of such artefacts and examples of how to 
deal with them.18–20 For example, the flow profile creates a (nearly) immobile layer 
above the sensor surface, which physically separates the immobilized ligands from 
the analytes in solution. The analyte has to diffuse through this layer to the surface 
(perpendicular to the flow). If this becomes limiting, the analyte concentration near 
the surface will start to differ from the bulk of the solution and the observed associa-
tion rates will be artificially limited (a situation known as mass transport limitation). 
Such deviating behaviour often has noticeably different traces in the sensorgram 
(Figure 1.2). When noticed, such situations can often be remedied by increasing the 
analyte concentration, decreasing the ligand concentration or higher flow rates. In 
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another example, most surfaces are easy targets for non-specific association, espe-
cially with biological samples. Commonly this is well countered by the use of a ‘ref-
erence’ surface, without immobilized ligand, to determine the non-specific binding 
and to subtract this from the total binding observed. Nevertheless, such corrections 
may introduce artefacts or mask interesting effects, and therefore it is almost always 
preferable to optimize buffer compositions and surface compounds to make sure 
such non-specific surface interactions are minimized. Additionally, as a result of 
immobilization on a surface, biomolecules may not remain in their native confor-
mation or the orientation can sterically interfere with analyte binding. When this is 
a problem, the inversion of the immobilized ligand and analyte in solution may solve 
this. However, often this is not possible and alternative immobilization strategies 
should be employed. 
Immobilization of biomolecules
Optimizing immobilization of a biomolecule on a sensor surface is key to the suc-
cess of a subsequent analysis. In particular retaining biological (binding) activity, 
the orientation, the density of immobilized biomolecules (to avoid steric hindrance 
and to control mass transport limitation), the reproducibility and regenerability of 
the surface (the ability to dissociate the analyte from the immobilized ligand with-
out compromising the ligand binding capacity) are to be considered.21 Additionally, 
non-specific binding of molecules to the surface or immobilization matrix should be 
minimized. The number of factors involved often result in a compromise, leading to 
Response (RU)
150
100
50
500 1000 1500 2000
Time (s)
Bivalent analyte
Mass-transport limited
Simple 1-to-1
Figure 1.2: Different situations result in different SPR sensogram traces. Here, the blue trace repre-
sent a simulation of a standard 1:1 interaction, the yellow trace the same interaction but in a situation 
of mass transport limitation and the green trace a similar interaction but with a bivalent analyte.
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a choice between the several options available for immobilizing biomolecules on a 
sensor surface: physical adsorption, hydrophobic interactions, electrostatic interac-
tions, covalent coupling or using affinity tags on molecules. The last two options are 
probably most frequently used due to affordable availability of materials, ease of use 
and stability.
Proteins and peptides are frequently immobilized using covalent amine coupling. 
A surface functionalized with carboxylic acids is activated with a succinimide-ester 
using a carbodiimide and can subsequently react with primary amines, available on 
the N-terminus and lysine side-chains of proteins and peptides (Figure 1.3).22 While 
rapid and inexpensive, this way of immobilization brings about random orientation 
on and multivalent attachment of the ligand to the surface, due to the presence of 
multiple amines in the ligand. The consequences of this are decreased conforma-
tional flexibility and steric hindrance of binding sites, thereby reducing the sen-
sitivity. Similar disadvantages are associated with biotinylation of protein ligands 
followed by streptavidin capture, when the biotinylation is based on the same 
non-specific amine coupling.
To reduce the negative effects of randomized amine-based ligand immobilization, 
more specific immobilization methods are required. On example are capture mol-
ecules: instead of the ligand, a molecule that strongly binds to the ligand, such as 
protein A for antibodies, an antibody against the ligand or an aptamer (an RNA or 
DNA molecule with specific ligand-binding properties),23 is coupled to the surface.24 
The functionalized surface is subsequently incubated with the target ligand, which 
is immobilized via its interaction with the capture molecule. Because this binding 
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Figure 1.3: Immobilization on a biosensor surface through amide coupling.
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typically is quite site-specific, a more homogeneous orientation and monovalent 
attachment can be achieved.25 However, high-affinity capture molecules are not 
readily available for all target ligands. 
Thus, a wide range of alternative strategies to achieve site-specific immobilization 
has been developed.26,27 A frequently used strategy is based on chemical coupling via 
less abundant chemical functionalities in proteins. For example, the thiol of cyste-
ines is not as abundant as amines and when multiple cysteines are present, a number 
of these may be unavailable for binding. This can allow reasonably specific ligand 
immobilization, either by the binding to a gold or thiol-functionalized surface,28 or 
by coupling to a thiol-reactive surface.29 A similar technique is to use the saccharides 
present on glycoproteins, which can readily bind to a surface functionalized with 
a boronic acid moiety.30 Alternatively, a protein ligand can be modified to provide 
a unique chemical ‘handle’. Such as the introduction of a non-natural amino acid, 
which through modification of the protein expression system allows orthogonal 
chemical moieties like an azide to be incorporated, which can easily be coupled 
using a ‘click-reaction’.31,32 Or the formation of a thioester to allow a native chemical 
ligation with a surface-bound cysteine.33
1.4. Peptide tags
An approach to providing a chemical ‘handle’ in a protein for site-specific immo-
bilization using more standard molecular biology, is the fusion of a peptide tag. 
Such a tag consists of a specific sequence of amino acids, which acts as recognition 
sequence or provides a specific affinity for a binding partner. Various properties of 
peptide tags can be of importance for coupling of biomolecules. Selecting the right 
tag for a desired application thus requires setting a priority in these properties. Two 
principal properties for this are the binding mode mediated by the tag (covalent 
or non-covalent) and whether a tag is self-contained or requires post-translational 
modification, for example by an enzyme (see Table 1.1). By defining the type of con-
jugation and the method by which it is established, these two properties usually play 
a key role in selecting the right tag for an application. 
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Covalent peptide tags
Covalently bound tags are stably conjugated in a wide array of environments. In bio-
sensor applications this could be important for sensor-reuse and longevity, because 
this may require the exposure to denaturing chemicals or harsh regeneration condi-
tions. Other applications, like protein-functionalized materials34,35 or antibody-drug 
conjugates36 often also benefit from such very stable conjugations and use similar 
systems. In covalent binding, peptide tags often function as recognition sequence 
for enzyme-mediated coupling. Several enzymes allow highly specific protein liga-
tion.37 Successfully employed examples are enzymes like sortase A, a cell-wall sorting 
enzyme that forms an amide bond between an LPXTG-peptide motif and an ami-
noglycine, and for which orthogonal and optimized variants have been engineered 
(Figure 1.4),38–42 or phosphopantetheinyl transferase, which in nature transfers 
a 4’-phosphopantetheinyl group from coenzyme-A to a serine of proteins tagged 
with the 11 amino-acid ybbR-tag to block the (enzymatic) activity of this serine. This 
behaviour can be used to post-translationally attach modified CoA-‘probes’ to pro-
teins of interest by fusion of the ybbR tag.43,44 
Covalent Non-Covalent
Enzyme-mediated Sortase, ybbR
⊕ Small, stable
⊖ Requires enzyme 
AviTag
⊕ Small, stable
⊖ Still sensitive to denaturing 
conditions, requires enzyme 
Self-contained SpyTag, inteins
⊕ Stable, self-contained
⊖ Relatively long tag-se-
quences involved 
Affinity-tags
⊕ Accessible, easy dissociation
⊖ Mostly weak-binding
Leucine-zippers
⊕ Self-contained, customizable, 
many varieties available
⊖ Stronger tags are usually 
relatively large and hydrophobic
Table 1.1: Overview of peptide tags.
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An interesting alternative to enzyme-mediated coupling is direct coupling using 
peptide motifs. Several natural proteins are autoreactive and allow direct cou-
pling of two polypeptides, used to lock protein domains in place once translated 
and folded.45 By splitting the reactive structure into two polypeptide sequences this 
reactivity is halted, but mixing of the polypeptides can cause reassembly in its high-
er-order structure, reconstituting the reactive centre and thereby covalently link-
ing the split polypeptide chains. Optimized for bioconjugation is the SpyCatcher/
SpyTag protein-peptide pair, a split and optimized version of the CnaB2 domain of 
the fibronectin binding protein FbaB of Streptococcus pyogenes, which forms a 
spontaneous isopeptide bond, an amide bond outside the normal polypeptide chain. 
Figure 1.4: Sortase-mediated immobilization of GFP on a gold surface. Sortase A recognises the 
peptide tag sequence and mediates and amide bond. (Reprinted from Colloids and Surfaces B: 
Biointerfaces, 128, Maryam Raeeszadeh-Sarmazdeh, Ranganath Parthasarathy, Eric T. Boder, Site-
specific immobilization of protein layers on gold surfaces via orthogonal sortases, 457-463, Copyright 
(2015), with permission from Elsevier)
Figure 1.5: Origins of the SpyCatcher/SpyTag system. A spontaneously formed isopeptide bond is 
used for covalent coupling by splitting the two coupling partners in separate polypeptide fragments. 
(Reprinted from Trends in Biotechnology, 32 / 10, Gianluca Veggiani, Bijan Zakeri, Mark Howarth, 
Superglue from bacteria: unbreakable bridges for protein nanotechnology, 506-512, Copyright (2014), 
with permission from Elsevier)
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Upon reconstitution of the 13 amino-acid tag with its 15 kDa protein partner, under 
influence of a neighbouring glutamic acid, the amine side-group of a lysine in the 
reactive centre can react with the carbonyl carbon of an aspartic acid side chain, 
covalently linking the split parts together (Figure 1.5).46,47 Similarly, inteins have been 
used. Inteins are protein sequences that are, post- or co-translationally, spliced out 
of the protein, breaking their N- and C-terminal peptide bonds and coupling the N- 
and C- terminally attached domains directly to each other.48 Some of these can be 
expressed or synthesized in two separate polypeptides of ~100 and ~35 amino-acids, 
so called split-inteins, which upon association undergo a trans-splicing reaction, 
linking previously separated N- and C-terminal polypeptides, while splicing out the 
intein fragments.49 
Non-covalent peptide tags
Sometimes, though, covalent binding is not desirable. Most often simply because at 
a later stage dissociation is required, which is non-trivial after a covalent coupling. 
Non-covalent tags are mostly self-assembling, requiring no mediating enzyme or 
other molecule. Compared with covalent autoreactive peptides, non-covalent tags 
are typically shorter and therefore allow more flexibility in fusion to the protein 
ligand and can more easily be synthesized, if desired. 
The most frequently applied non-covalent tags are affinity tags. Due to their fre-
quent use in recombinant protein purification, they are also obvious candidates for 
downstream applications like immobilization on a biosensor. Although over time 
many variations of affinity tags have been developed,50,51 the most popular tag is the 
hexahistidine tag (His-tag), consisting of 6 histidines, which can coordinate with 
cobalt-, nickel-, copper-, or zinc-ions, typically immobilized through nitrilotriacetic 
acid (Figure 1.6).52 The principle of affinity-tags depends on binding with moderate 
Figure 1.6: Ligand immobilization through a His-tag on a NTA-functionalized surface, mediated by 
Ni-ions.
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strength to a specific binding partner and easy removal by addition of a competitor 
with higher affinity or a change in conditions resulting in reduced affinity of the tag. 
Besides the His-tag, this principle is also used in the slightly less frequently applied 
Strep-tag53,54 or FLAG-tag55, which rely on a streptavidin-binding peptide and a spe-
cific pair of a high-affinity antibody and peptide epitope, respectively.
However, while highly successful for short capture during purification, such affinity 
tags have one major disadvantage: due to their relatively moderate affinity (a typical 
K
D
 is ~1 µM,53,56 although the antibody-FLAG-tag interaction is somewhat stronger) 
their dissociation rate is high enough to be of considerable influence in the time-
frame of biosensor applications. To counter this problem, tags consisting of inter-
twining peptide sequences have been adopted from nature, usually structured in a 
coiled-coil motif. This unique structure, in which one helical peptide coils around 
another helical peptide, creates a set of multiple interlocking interactions, which 
can be considered as a kind of peptide Velcro or zipper, and display high affinities.57 
One of the first examples of these peptides was inspired by the dimerization domain 
of eukaryotic transcription factors, which have a highly hydrophobic interface along 
an alpha helix that causes the helices to stick together in the coiled-coil. The leucine 
residue repeated at every second turn of the helix gave rise to the name leucine 
zipper.58 Later studies revealed that these leucine zippers can be tuned, mostly by 
modification of the hydrophobic residues at position a and d and the charge of the 
residues at position e and g in the helix (Figure 1.7). A wide array of artificial pep-
tides have been designed, for example to vary the dimer affinities from micro- to 
femtomolar59–61 or to create orthogonal sets of peptides.62,63 The predictability of the 
coiled-coil structure allows computerized design64 and self-assembly of well-defined 
Figure 1.7: Schematic representation of the interactions in a leucine zipper. The red and blue cylin-
ders represent the two α-helices, with in yellow the hydrophobic a and d positions and in purple the 
charged e and g positions.
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peptide-nanostructures such as cages65,66 and tetrahedrons.67,68 Due to their relatively 
easy production, high affinity and well-defined structure these coiled-coil peptide 
tags are an excellent candidate for protein immobilization on biosensors.69,70
One other tag deserves to be mentioned, the AviTag: a post-translational biotinyla-
tion of a specific peptide sequence by the BirA enzyme.71,72 This combines the advan-
tages of binding strength of the biotin-streptavidin interaction and ready availability 
of streptavidin-functionalized sensor surfaces with site-specific conjugation. The 
BirA enzyme specifically recognizes the optimized sequence GLNDIFEAQKIEWHE and 
post-translationally adds a biotin moiety to the lysine (Figure 1.8). This can be per-
formed as a separate step in vitro, but the co-expression of BirA with the tagged 
protein of interest is also possible.73 Depending on the application the AviTag can 
either be the best or worst of both worlds in the categorization above: although it is 
non-covalent, it does form a very strong interaction with streptavidin, which is not 
easily broken. For most purposes this is on par with a covalent tag, without the need 
for specific reaction conditions or a catalytic enzyme during conjugation. On the 
other hand, unlike most other non-covalent tags, it requires a separate post-trans-
lational modification. And, unlike most covalent tags, it has the protein streptavidin 
as binding partner, which is relatively large and has the potential to lose binding 
capacity, for example under denaturing conditions. 
1.5. Outline
It is clear that the analysis of biomolecular interactions is a multifaceted field of 
study, where all components need to be tuned to achieve an optimal outcome and 
that the end result is often a compromise. This thesis describes our efforts to improve 
elements of biomolecular interaction analysis and its applications.
Figure 1.8: Schematic of AviTag functionality. The AviTag sequence is specifically biotinylated by the 
BirA enzyme, allowing immobilization to streptavidin-functionalized surfaces.
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Chapter 2 describes a method to use novel multiplex SPR equipment to facilitate 
the optimization of regeneration conditions, which are used to dissociate the ana-
lyte from the immobilized ligand. The required conditions weaken the ligand-ana-
lyte interaction, without compromising the ligand binding capacity for subsequent 
analyses, and are often difficult to predict, resulting in a trial-and-error process. 
Using a continuous-flow microspotter, multiple regeneration conditions can be 
tested simultaneously in a single experiment. By subsequently testing the efficiency 
of regeneration by incubating the surface with analyte and quantifying binding by 
surface plasmon resonance imaging, a rapid optimization of regeneration conditions 
can be achieved.
In Chapter 3 a novel method for immobilization of proteins on a biosensor surface 
is introduced. The sensor surface is functionalized with zwitterionic peptide mole-
cules, from which leucine zipper peptides protrude. Proteins can be immobilized to 
this layer via a simple incubation with proteins fused to the complementary leucine 
zipper sequence. The immobilized proteins are subsequently visualized via antibody 
binding with multiplex surface plasmon resonance imaging. This method produces 
uniform functional protein arrays with control over ligand orientation and con-
served biological activity.
An application of biomolecular interaction analysis by multiplex SPR imaging is 
presented in Chapter 4, where we demonstrate an improved method for profiling 
of anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis. These ACPA, 
which are used in diagnosis and management of rheumatoid arthritis, are directed to 
a heterogeneous mixture of citrullinated targets. This allows profiling of sub-speci-
ficities, which is facilitated by the use of multiplex microarrays that allow screening 
of reactivities against multiple epitopes simultaneously. By using a proxy for antibody 
titers from binding kinetics under mass transport limited conditions, reproducibility 
is improved, variance from peptide immobilization reduced and incubation times 
shortened, allowing multiple analyses in the same amount of time.
In Chapter 5, the tags developed in Chapter 3 are applied to specifically immobilize 
a single monomer from a multimeric complex of small heat-shock proteins. These 
complexes are dynamic, with subunits entering and leaving, which seems to be 
related to chaperone activity for at least one small heat-shock protein, αB-crystallin. 
The dynamics of this behaviour appears to vary in a pH-dependent manner. A model 
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of the binding behaviour of these complexes to single subunits immobilized on a 
surface is developed, based on previous studies to the changing distribution of the 
number of subunits in a complex. The model is then tested by immobilization of a 
single monomer on an SPR chip and the analysis of complex assembly on the chip.
Chapter 6 describes our work towards the use of leucine zipper peptide tags in cell-
based applications. The ability to use leucine zippers to trigger cellular import of a 
protein cargo is demonstrated through coiled-coil activated cell-penetrating pep-
tides, which are inert when alone, but can be activated upon addition of a com-
plementary peptide. Additionally, we show the feasibility of using these peptides 
intracellularly by expression fused to fluorescent proteins and monitoring their 
dimerization. This controlled complex formation can be a useful tool for future 
manipulation of intracellular processes.
Finally, the discussion in Chapter 7 connects the results from the preceding chapters 
and looks into the future.
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ὅτι δὲ γίγνεται ἀτμίζουσα πότιμος καὶ οὐκ εἰς θάλατταν συγκρίνεται τὸ 
ἀτμίζον, ὅταν συνιστῆται πάλιν, πεπειραμένοι λέγωμεν. πάσχει δὲ καὶ τἆλλα 
ταὐτό· καὶ γὰρ οἶνος καὶ πάντες οἱ χυμοί, ὅσοι ἂν ἀτμίσαντες πάλιν εἰς 
ὑγρὸν συστῶσιν, ὕδωρ γίγνονται· πάθη γὰρ τἆλλα διά τινα σύμμειξιν τοῦ 
ὕδατός ἐστιν, καὶ οἷον ἄν τι ᾖ τὸ συμμειχθέν, τοιοῦτον ποιεῖ τὸν χυμόν.
Salt water when it turns into vapour becomes sweet, and the vapour does 
not form salt water when it condenses again. This I know by experiment. The 
same thing is true in every case of the kind: wine and all fluids that evaporate 
and condense back into a liquid state become water. They all are water mod-
ified by a certain admixture, the nature of which determines their flavour.
Aristotle, classical philosopher and scientist 
Meteorologica, ca. 350 BC
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Various analytical techniques for biomolecular interactions depend on a surface with immobilized (bio-)molecules. After binding, bound analytes are typically 
removed by surface regeneration to allow subsequent measurements. The regen-
eration conditions needed can vary dramatically and have to be optimized for each 
analyte, which may be time-consuming. A continuous flow microspotter was used 
to assess multiple regeneration conditions in parallel in a single experiment. The 
efficiency of regeneration was determined by incubating the surface with analyte 
repeatedly and quantifying analyte binding by surface plasmon resonance imaging. 
The combination of continuous flow microspotting and surface plasmon resonance 
imaging allowed rapid optimization of regeneration conditions, applicable to immo-
bilization methods based on covalent and non-covalent surface chemistries. 
2.1. Introduction
Interactions between biomolecules are important biological events and are exten-
sively investigated in the field of life science research, generally by applying bio-
sensors. Immunology, drug discovery, proteomics and food research are just a few 
examples of areas of study where biosensor analysis of biomolecular interactions is 
frequently applied.1,2 Biosensors are usually based on a label-free method to detect 
binding. Examples of such methods are electrochemical sensing, where binding 
of an analyte results in a concentration dependent electrical signal, quartz crystal 
microbalances, which detect changes  in mass through a change in resonance fre-
quencies, and optical sensors, which detect changes in mass through variations in 
refractive index.3,4 
In a typical biosensor a ligand is immobilized onto a solid surface and the associ-
ation and dissociation of an analyte in a liquid phase is monitored. After one such 
measurement cycle the analyte is completely removed by regenerating the ligand 
surface in preparation for a next measurement cycle, allowing reuse of the ligand 
surface for multiple analytes in series. Protocols that avoid the need for regeneration 
by correcting for the reduced amount of binding over multiple measurements using 
a calibration curve5 or a kinetic titration method6 only have limited applications, 
since the number of measurements that can be done on a single surface is relatively 
small and the results may be affected by the additional material on the surface. 
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The experimental condition of the regeneration step is critical for the quality of sub-
sequent measurements: too harsh regeneration will damage the immobilized ligand 
and too mild regeneration will not completely remove the analyte. Both of these 
conditions will diminish the binding capacity of the immobilized ligand. Finding 
the optimal regeneration condition is often a process of trial and error, if possible 
guided by physicochemical features of the interaction that needs to be disrupted. 
For example, an interaction that is strongly mediated by electrostatic forces is likely 
to be weakened by the presence of high salt concentrations. If such information is 
not available or the interactions are stabilized by multiple chemical interactions, a 
systematic approach is desirable. This may be achieved by using a series of cock-
tail solutions,7 containing different combinations of compounds, and/or the use of 
a systematic decision tree, which starts with a few broad spectrum conditions and 
converges on the desired condition in a couple of steps.8 
In order to facilitate a rapid evaluation of multiple regeneration conditions simulta-
neously, a multiplex approach is desirable. Geuijen and coworkers recently presented 
a proof of concept of such an approach.9  Using a continuous flow microspotter in 
combination with a microarray-based optical sensing technique, called surface plas-
mon resonance (SPR) imaging,10 a multitude of conditions could be screened in par-
allel. The assessment of a large number of conditions in a single experiment greatly 
reduced the time necessary for optimization of experimental conditions. Here, we 
investigated the robustness and versatility of this approach by a modified proto-
col with repeated cycles of association and regeneration, mimicking consecutive 
analyte binding experiments. The general applicability of this regeneration scouting 
procedure was investigated for three distinct analyte-ligand combinations, of which 
two ligands were covalently and one ligand non-covalently immobilised. 
2.2. Materials & Methods
Expression and purification of αB-crystallin
Recombinant human αB-crystallin was expressed from a pET16b vector by transformation of E. 
coli BL21 Rosetta. These were cultured in 450 mL LB broth containing 100 µg/ml ampicillin at 37 
°C until an optical density of 0.35 was reached. Expression was induced by addition of 800 µM 
isopropyl β-D-1-thiogalactopyranoside, after which bacteria were cultured for 3 hours at 37 °C. 
Cultures were pelleted and resuspended in 15 mL TEG50, pH 8.0 (25 mM Tris-HCl, 2 mM EDTA, 50 
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mM glucose), lysed by sonication and cleared by centrifugation for 45 min at 100,000 g. Nucleic 
acids were precipitated from the supernatant by gradual addition of 0.12% poly(iminoethylene) 
and centrifugation for 10 min at 4,250 g. The supernatant was fractionated on a DEAE fast flow 
column using a 0 – 1 M NaCl gradient in 25 mM Tris-HCl, 2 mM EDTA, pH 8.0. After desalting, it 
was further fractionated using a Source 15Q HR 16/10 column using the same gradient. Purified 
αB-crystallin containing fractions were pooled and dialysed against 25 mM Tris-HCl, 100 mM 
NaCl, 2 mM EDTA, pH 6.2 and were frozen in liquid N2 and stored at -20 °C.
Protein immobilization and regeneration
Human serum albumin (Hoffman-La Roche, Basel, Switzerland) was immobilized on a SensEye 
Easy2Spot-G SPR imaging sensor (Ssens, Enschede, The Netherlands), containing a gel-type 
surface with NHS-ester functionality by incubation of a 100 µg/mL solution in 20 mM sodium 
acetate, pH 4.6 with the pre-activated surface for one hour in the flow cell of an IBIS MX-96 iSPR 
instrument (IBIS Technologies, Enschede, The Netherlands). The surface was quenched by wash-
ing with 1 M 2-aminoethanol in 100 mM MES (2-(N-morpholino)ethanesulfonic acid), pH 5.5 for 
8 minutes. Following immobilization, the baseline response of the albumin surface at regions of 
interest  was established by binding polyclonal rabbit anti-albumin IgG (1:100 dilution of A0433, 
Sigma-Aldrich, St. Louis, MO, USA) in PBSt (phosphate buffered saline containing 0.075% Tween-
80) for 40 minutes at 25 °C. 
For regeneration, the sensor was washed with PBSt and transferred to a continuous flow micro-
spotter (Wasatch Microfluidics, Salt Lake City, UT, USA) and specific spots, each containing a 
defined region of interest, were incubated for two minutes with the regeneration solutions 
listed in the figures. After incubation, the spots were washed for two minutes with PBSt and the 
binding response was measured as before in the iSPR instrument, which allows the analysis of 
the regions of interest.
αB-crystallin was immobilized as a multisubunit complex in a similar way as described for 
human serum albumin. Afterwards, the surface was regenerated to remove the non-crosslinked 
subunits.  Binding experiments were performed using at 20 °C by incubating for 15 min with 
αB-crystallin 0.5 mg/mL in PBSt, pH 6.8 (diluted from a stock of 4.2 mg/mL in 20 mM sodium 
acetate, pH 4.6). The cycle of regeneration and binding was repeated three times.
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Peptide immobilization and regeneration
A citrullinated peptide (HQCESTXGRSRGRCGRSGS–6-hexanoic acid–Lys-biotin, where X is cit-
rulline) was immobilized on a SensEye Strep-G SPR imaging sensor (Ssens, Enschede, The 
Netherlands) by incubation for one hour with 0.5 µg/mL of peptide11 in PBSt in the flow cell of 
an IBIS MX-96 iSPR instrument. After immobilization, the  binding response was determined 
during 50 minutes with an ACPA-positive patient serum, 20-fold diluted in PBSt.12 The surface 
was then regenerated as described under Protein immobilization and regeneration, and ACPA 
binding was evaluated as before regeneration.
Data analysis
Response values were acquired using SPRintX (IBIS Technologies, Enschede, The Netherlands) 
by determination of the response at the end of the programmed association time. When appli-
cable, the signal recovery was determined by calculating the percentage of response after 
regeneration compared to the response before any regeneration was performed for the same 
region of interest. Significance of the difference in binding response after regeneration with the 
various solutions was assessed with a one-way, repeated measures ANOVA with Dunett-test, 
using the results obtained for PBSt as control signal. Statistical analyses were performed using 
Graphpad Prism 5 (Graphpad Software, La Jolla, CA, USA).
1
2
3 (microspotter)
4 (SPR imaging)
I II III
Figure 2.1: Screening regeneration conditions. In step one, an SPR imaging chip (yellow) is covered 
with ligand (cyan). In step two, the chip with immobilized ligand is saturated with analyte (red). In 
step three, a series of spots on the chip (in this example 3 of the maximum 48 spots are indicated) 
are locally exposed to regeneration solutions in a continuous flow microspotter, resulting in no 
(I), partial (II) or full regeneration (III). At the regions around the spots the analyte remains bound 
(blurred colored). In step four, the binding of the analyte is measured by SPR imaging at regions of 
interest located within the spots, where the binding response indicates regeneration efficiency. Step 
3-4 can be repeated multiple times to assess the reproducibility and the robustness of the coated 
chip surface. 
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2.3. Results and Discussion
For screening regeneration conditions, the entire surface of an SPR imaging chip was 
covered with immobilized ligand and incubated with analyte. After analyte binding, a 
series of spots on the chip were locally exposed to different regeneration solutions in 
a continuous flow microspotter. This microspotter consists of a polymer printhead, 
which is pushed onto the chip surface, connected to a well-plate with solutions. The 
continuous flow can be applied to spots on the chip by using microfluidic flow cells 
etched in the printhead, of which one side is in contact with the surface. After regen-
eration, the efficiency of regeneration was determined by incubating the surface 
with analyte again and quantifying the amount of analyte binding by SPR imaging at 
regions of interest defined within the spots (Figure 2.1).
The feasibility of this approach was first tested with recombinant human albumin as 
ligand and purified anti-albumin antibodies as analyte. Albumin was coupled to the 
entire surface of an N-hydroxysuccinimide activated chip in an SPR imaging flow 
cell; subsequently, the immobilized albumin was incubated with anti-albumin anti-
bodies. The SPR response generated during anti-albumin binding established a ref-
erence response level. Subsequent measurements were expected to reproduce this 
level when regeneration would be optimal. Next, distinct spots on the surface were 
incubated with a variety of regeneration conditions which are frequently applied to 
disrupt protein-protein interactions, such as highly acidic or basic pH, high salt and 
chaotropic conditions.13 The regeneration efficiency was established by measuring 
the amount of anti-albumin antibody able to bind again in the SPR imaging flow cell. 
If conditions were either too harsh or too mild, antibody-binding during this second 
measurement would be reduced due to either removal/destruction of the ligand or 
to (partial) blocking of ligand by remaining analyte. The reproducibility of the proce-
dure was determined by multiple consecutive regeneration–analyte-binding cycles.
For a typical iSPR measurement at least two types of regions of interest are defined: 
one to measure total binding on the spot where ligand is immobilized and one on the 
surface between the spots (reference areas), to correct for non-specific interactions. 
Because in our multiplex regeneration experiments the ligand was immobilized on 
the entire surface to create an equal distribution across the surface, the analysis 
of reference areas on the chip was not possible. As a consequence, the non-spe-
cific interactions of the antibody with the surface could not be subtracted from 
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the obtained signals. Since these interactions are generally weak, they are easily 
disrupted under mild washing conditions. Therefore, as a reference the standard 
buffer, phosphate buffered saline containing 0.075% Tween-80 (PBSt), was used, 
which removes any weakly, non-specifically bound antibodies.  The signal recovery 
observed with PBSt was about 30% of the initial binding signal (Figure 2.2), which 
indicates that 70% of the original signal represented specific analyte binding. 
The results for regeneration of the albumin surface (Figure 2.2) show that acidic 
conditions, in particular pH 1.3, were optimal for regeneration as the response 
after regeneration approached the signal before regeneration and remained stable 
Figure 2.2: Regeneration efficiency of covalently immobilized human albumin bound to anti-albumin 
IgGs. a) Regeneration efficiency is determined by comparison of repeated association responses with 
the baseline association acquired immediately after immobilization. b) Regeneration efficiency with 
a number of common regeneration solutions. Data represent the mean with standard deviation of 
triplicate analyses. Significance of the differences compared to PBSt (*: P ≤ 0.05, **: P ≤ 0.01, ***: 
P ≤ 0.001, ns: not significant) was assessed by a one-way repeated measures ANOVA with Dunett’s 
test. c) A typical example of sensorgrams before and after regeneration with either PBSt or 10 mM 
glycine-HCl pH 1.3.
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over three regeneration cycles. This matches the common practice to disrupt anti-
body-antigen interactions via low pH incubation.12,14 Other conditions resulted in 
only low levels of regeneration or inhibited subsequent binding to the immobilized 
albumin. Guanidine-HCl (6 M), for example, resulted in a decrease in signal with every 
regeneration cycle, most likely caused by partial denaturation of the ligand, thereby 
obscuring a fraction of its epitopes. 
Next to regeneration of a surface with a well-defined antibody-antigen interaction, 
this approach was used to scout conditions that lead to the disruption of other, less 
well defined protein-protein interactions. To this end, the small heat-shock protein 
Figure 2.3: Disassembly conditions of multimeric αB-crystallin complexes. a) After immobilization, 
αB-crystallin complexes are disrupted and the surface regenerated. Binding responses during sub-
sequent associations are a measure for the regeneration of the surface. b) Binding responses after 
regeneration with a number of common regeneration solutions. Data represent the mean with stand-
ard deviation of triplicate analyses. Significance of the differences compared to PBSt (*: P ≤ 0.05, ***: 
P ≤ 0.001, ns: not significant) was assessed by a one-way repeated measures ANOVA with Dunett’s 
test. c) A typical example of sensorgrams after regeneration with either PBSt or 10 mM glycine-HCl 
pH 1.3.
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αB-crystallin was covalently immobilized on an SPR imaging sensor. αB-crystallin 
forms multimeric complexes containing multiple αB-crystallin polypeptides that 
exist in a dynamic equilibrium 15. The disassembly of such large protein complexes 
can be studied using regeneration scouting. Analysis of the conditions under which 
these complexes are disrupted may give further insights in the stability and dynam-
ics of these complexes.  
After immobilization, αB-crystallin complexes were disassembled during the 
regeneration step, leaving only the covalently linked molecules at the surface. The 
responses obtained during three cycles of regeneration and subsequent binding 
of αB-crystallin are depicted in Figure 2.3. In this case no regeneration efficiency 
was calculated. This is due to the fact that αB-crystallin was immobilized as ligand/
analyte couple and as a consequence of the lack of an initial analyte binding step, 
no initial response level could be measured (compare Figures 2a and 3a). The bind-
ing responses can be compared relative to each other and show that the surface 
could best be regenerated with most of the relatively harsh conditions: 6 M guan-
idine-HCl, 1.5 M sodium thiocyanate, glycine-HCl, pH 1.3 and pH2.0, and 100 mM 
sodium hydroxide. Similar binding responses were observed after multiple regener-
ation cycles indicating that under these conditions the subunits covalently bound to 
the surface remained intact. Guanidine-HCl and sodium hydroxide likely disassemble 
the multimeric complexes by denaturation of the protein subunits, after which the 
covalently bound subunits may refold again. The mild chaotrope sodium thiocya-
nate may disassemble the complexes by protein-protein repulsion.16 The low pH may 
change the properties of the binding interface at a low pH. The acid-sensitivity of 
αB-crystallin–αB-crystallin interactions is in agreement with the results of structural 
studies, which revealed several acid-sensitive intramolecular salt bridges that are 
critical for complex stability.17,18 
While the regeneration scouting method is applicable for solutions of purified ana-
lyte and covalently immobilized ligands, SPR imaging is widely employed in other 
experimental setups. Frequently, ligands are immobilized non-covalently, making 
optimization of regeneration conditions more critical, as these are more prone 
to dissociation under harsh conditions. Also, analyte solutions can have complex 
molecular compositions, like serum/plasma, milk or food-extract,12,19 resulting in 
noisier measurements. The applicability of the regeneration scouting method under 
such conditions was tested for a specific example, the detection of autoantibodies 
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in sera from patients with autoimmune diseases. Anti-citrullinated protein antibod-
ies (ACPA), which recognize deiminated arginine (citrulline) containing epitopes, 
are among the most pronounced serological biomarkers for rheumatoid arthritis.11 
Presence of ACPA in patient sera is generally tested by assessing reactivity of the 
sera with defined synthetic citrullinated peptides. For this test, a streptavidin coated 
SPR imaging sensor was incubated with a biotinylated variant of a cyclic citrulli-
nated peptide that is recognized by ACPA,11,12 leading to the non-covalent immobi-
lization of the peptide on the surface. The sensor was subsequently incubated with 
diluted ACPA-containing patient serum to allow ACPA to bind. After subsequent mul-
tiplexed regeneration of the sensor surface in the continuous flow microspotter, the 
Figure 2.4: Regeneration efficiency of streptavidin-captured citrullinated peptides with diluted ACPA-
containing serum. a) Regeneration efficiency is determined by comparison of repeated association 
responses with the baseline association acquired immediately after immobilization. b) Regeneration 
efficiency with a number of common regeneration solutions. Data represent the mean with standard 
deviation of triplicate analyses. Significance of the differences compared to PBSt (*: P ≤ 0.05, **: P ≤ 
0.01, ***: P ≤ 0.001, ns: not significant) was assessed by a one-way repeated measures ANOVA with 
Dunett’s test. c) A typical example of sensorgrams before and after regeneration with either PBSt or 
10 mM glycine-HCl pH 1.3.
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efficiency of regeneration was assessed by consecutive incubations with the same 
serum. The results in Figure 2.4 show that efficient regeneration was observed by 
the exposure to 6 M guanidine-HCl, 1.5 M sodium thiocyanate, 2 M magnesium chlo-
ride, and highly acidic conditions. Although also 100 mM sodium hydroxide resulted 
in efficient regeneration, consecutive regeneration steps resulted in a decrease in 
the response, which is most likely due to deterioration of the underlying streptavi-
din layer. As before, dissociation by guanidine-HCl was expected to be due to dena-
turation. The difference between sodium- and magnesium chloride in regeneration 
efficiency is likely due to the additional charge of divalent cations. Acidic buffers and 
sodium thiocyanate have been used before to disrupt antibody-antigen interactions, 
but these results show that small differences in pH can affect regeneration efficiency 
and these conditions should therefore be carefully selected. 
Taken together, the presented method provides an efficient way for selecting regen-
eration conditions. Its parallel analyses provide speed and scalability, as the number 
of time-consuming analyte incubations is largely independent of the number of con-
ditions to be screened individually.  The three successive analyte incubations pro-
vide additional information on the stability over multiple regenerations, and require 
less time compared to previously described screening protocols,7,8 which require 
many more injection steps. A possibility for future improvement is the integration of 
the currently used devices, the microspotter for regeneration and the iSPR instru-
ment for analysis, to eliminate off-line handling.
Our data show that microspotter-based regeneration scouting is versatile and appli-
cable to a variety of molecular interactions and experimental setups. It can be applied 
to covalently immobilized proteins, but also to molecules immobilized by alternative 
chemistries, like biotin-streptavidin capture. Moreover, the results obtained with a 
crude analyte solution (antibody-containing serum) show that this method can also 
be used for the optimization of regeneration conditions with analytes in complex 
mixtures of molecules.
Besides the selection of optimal regeneration conditions for sensor surfaces bound 
by analytes, this approach also provides possibilities to study the stability of pro-
tein-protein interactions under a wide range of conditions in a single experiment. 
Analysis of the stability under various conditions can provide insight in the types 
of chemical bonds involved. In addition, a concentration series of mild, partially 
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regenerating conditions may be used to analyse the avidity of multivalent analytes, 
such as antibodies,12,20 which may be relevant in monitoring disease progression or 
for the assessment of a panel of monoclonal antibodies. Therefore, the simultaneous 
analysis of regeneration conditions by our procedure can provide a relatively fast 
and simple way to gain understanding of the importance of various types of interac-
tions that can play a role in the interaction between two biomolecules. 
2.4. Conclusions
The combined use of an iSPR instrument and a continuous flow microspotter for 
multiplex screening of regeneration conditions provides a method that allows the 
rapid optimization of sensor surface regeneration. This approach can also be used 
for the assessment of the most important physicochemical bonds mediating bio-
molecular interactions. The optimization of regeneration can be performed with 
ligands immobilized via covalent as well as non-covalent surface conjugation chem-
istries, and with crude as well as purified analytes. By scouting multiple conditions 
simultaneously on a single chip, optimal conditions for regeneration can be deter-
mined in half a day. This allows researchers to test a larger number of conditions for 
regeneration of their biosensors. 
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We have developed an integrated solution for the site-specific immobiliza-tion of proteins on a biosensor surface, which may be widely applicable for 
high throughput analytical purposes. The gold surface of a biosensor was coated with 
an anti-fouling layer of zwitterionic peptide molecules from which leucine zipper 
peptides protrude. Proteins of interest, in this the autoantigenic proteins La and U1A, 
were immobilized via a simple incubation procedure by using the complementary 
leucine zipper sequence as a genetically fused binding tag. This tag forms a strong 
coiled-coil interaction that is stable during multiple consecutive measurements and 
under common regeneration conditions. Visualization of the immobilized proteins 
of interest via antibody binding with multiplex surface plasmon resonance imaging 
demonstrated 2.5 times higher binding responses than when these proteins were 
randomly attached to the surface via the commonly applied activated ester-medi-
ated coupling. The proteins could also be immobilized in a leucine zipper-dependent 
manner directly from complex mixtures like bacterial lysates, eliminating the need 
for laborious purification steps. This method allows the production of uniform func-
tional protein arrays by control over immobilized protein orientation and geometry 
and is compatible with high-throughput procedures.
3.1. Introduction
Interactions between biomolecules play a crucial and complex role in biological 
systems. This makes reliable and sensitive methods to study these interactions an 
important tool in (bio)chemical and medical research. A sensitive and versatile tech-
nique for label-free, real-time detection of such interactions is Surface Plasmon 
Resonance (SPR).1 Like many of the methods for detection of biomolecular interac-
tions, it relies on immobilization of biologically active molecules on a solid surface. 
The most commonly applied immobilization chemistry uses an activated ester func-
tionalized surface to couple primary amines, present on the N-terminus or lysine 
side chains of proteins and peptides.2–4 The widely applied amine-based coupling 
chemistry leads to surface heterogeneity due to variations in orientation, steric hin-
drance and multivalent binding of the ligand.5 This is suboptimal for sensitivity and 
creates variability between measurements.
To improve ligand immobilization, several strategies for site-specific protein immo-
bilization have been developed.6,7 Some of these utilize bio-orthogonal reactions 
like copper-catalyzed and strain-promoted ‘click’ chemistry,8–11 oxime ligation10,12 
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Staudinger ligation13 or enzymatic coupling reactions as those with sortase14 or 
phosphopantetheinyl transferase.15 Others make use of non-covalent binding, such 
as facilitated by the use of affinity tags frequently used for protein purification16–20 
or peptide tags that bind to the surface matrix, like pMMA.21 More alternatives are 
DNA-directed immobilization22,23 or enzymatic modification of the proteins,24–26 like 
localized biotinylation of a specific peptide tag using the BirA enzyme.27 However, 
these methods either rely on separate modification and coupling steps of the pro-
teins involved, or have relatively weak binding properties. 
Advances in SPR technology also put different demands on the immobilization chem-
istry. Surface Plasmon Resonance Imaging (iSPR) is a multiplex variant that is primar-
ily used for the visualization of biomolecular interactions, generally on microarrays.1 
With this approach, instead of a single biomolecule, multiple different biomolecules 
need to be immobilized simultaneously. As a consequence, coupling or modification 
steps that need individual optimization for distinct biomolecules, are undesirable. 
An immobilization method that is specific, strong and well controlled, yet versatile 
and simple enough to be used for multiple different biomolecules is not yet available. 
Versatile, specific and strong binding can be found in so-called leucine zipper pol-
ypeptides. These are coiled-coil binding motifs, originating from the bZIP class of 
transcriptional regulator proteins.28 Their structure consists of a heptad repeat 
with a hydrophobic leucine on the binding interface, which gives them their name. 
Next to these leucines, the binding interface contains pairs of oppositely charged 
residues. By variation of these charged residues, affinity and specificity of leucine 
zippers can be engineered, and sets of heterospecific leucine zipper peptides have 
1
2
3
Benchtop      Microspotter         iSPR
Figure 3.1: Schematic representation of leucine-zipper mediated immobilization. Initially the gold 
surface of an iSPR biosensor is coated with anti-fouling peptides mixed with anti-fouling peptides 
extended with leucine zippers (1). One or more fusion proteins containing a single complementary 
leucine zipper peptide are then immobilized on the surface by incubation in a microspotter (2). 
Following immobilization antibody binding to the immobilized proteins is visualized using iSPR (3).
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been developed.29,30 By optimizing binding strength, binding affinity up to a disso-
ciation constant of 10-15 M has been obtained, comparable to the well-established 
biotin-streptavidin interaction.31 Zhang et al. successfully applied leucine zipper pol-
ypeptides for immobilization of proteins, although in their approach an additional 
crosslinking reaction was still needed to functionalize the surface.32 Immobilization 
with coiled-coil domains was also shown by Ferrari et al., using the larger tetra-hel-
ical SNARE protein complex as connector.33
3.2. Materials & Methods
Cloning
An XhoI restriction site was introduced between the oligohistidine tag sequence and the attL1 
site of a pDEST17 vector by site-directed mutagenesis.  Partially overlapping oligonucleo-
tides coding for the leucine zipper peptides ER (LEIEAAFLERENTALETRVAELRQRVQRLRNRVS-
QYRTRYGPLGGGGK) and RE (LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETRYGPLGGGGK) 
flanked by XhoI sites (Biolegio, Nijmegen, The Netherlands) were converted to double-stranded 
molecules by PCR, digested by XhoI (New England Biolabs, Ipswitch, MA, USA) and the inserts 
isolated. The inserts were then ligated into the XhoI-linearized pDEST17 variant described 
above. E. coli ccdB survival 2 T1R competent cells were transformed with these constructs and 
grown on media with 100 µg/mL carbenicillin and 34 µg/mL chloramphenicol. This resulted in 
the pDNz-VinER and pDNz-VinRE plasmids (see Supplementary Figures 3.7 and 3.8). La and U1A 
cDNAs were generated by PCR using cDNA constructs described previously34,35 and introduced 
into pENTR/TEV/D-TOPO vectors. Subsequently these were recombined in an LR-recombination 
reaction with pDEST17 and pDNz vectors using Gateway LR Clonase II mix and  the resulting 
pDEST17-La, pDEST17-U1A, pDNz-VinER-La, pDNz-VinRE-La, pDNz-VinER-U1A and pDNz-Vin-
RE-U1A vectors were used to transform E. coli TOP10 competent cells. Following plasmid iso-
lation, the integrity of all constructs was confirmed by DNA sequencing. Cloning supplies were 
acquired from Invitrogen (Carlsbad, CA, USA) and chemicals from Sigma-Aldrich (St. Louis, MO, 
USA).
Protein Expression
The constructs for the expression of unmodified and N-terminally leucine zipper-tagged U1A 
and La proteins were used to transform E. coli BL21 AI. An initial overnight culture in 5 mL LB 
was used to inoculate 1.5 L 2TY medium containing 100 µg/mL ampicillin. The bacteria were 
cultured at 37 °C and expression was induced (at OD 0.7) using 0.1% of L-arabinose and 0.5 mM 
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isopropyl β-D-1-thiogalactopyranoside (MP Biomedicals, Santa Ana, CA, USA), after which the 
bacteria were cultured overnight at 25 °C. Cells were harvested and resuspended in 20 mM Tris-
HCl, pH 8.0, 500 mM KCl for Ni-NTA affinity purification or PBS for direct immobilization, lysed 
by sonication and cleared by centrifugation for 20 min at 29,000 g. For direct immobilization 
the crude lysates were cleared by gradual addition of poly(iminoethylene) to 0.02% and cen-
trifugation for 20 min at 29,000 g. Lysates were then frozen by liquid nitrogen and stored in sin-
gle-use aliquots at -80 °C. For purification the lysates were incubated with Ni-NTA sepharose (IBA 
Life Sciences, Goettingen, Germany) and the suspension was cast in a column. The column was 
washed with wash buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 20 mM imidazole, 10% glycerol), 
wash buffer containing 1 M KCl and wash buffer containing 50 mM imidazole. Bound proteins 
were eluted (20 mM Tris-HCl, pH 8.0, 100 mM KCl, 500 mM imidazole, 10% glycerol) and analysed 
by SDS-PAGE.  The buffer was then exchanged to PBS and samples were concentrated using 10 
kDa MWCO centrifugation filters (EMD Millipore, Billerica, MA, USA). 
Peptide Synthesis
Peptides were synthesized using standard Fmoc chemistry on Barlos resin. The resin was swollen 
in dimethylformamide (DMF). Fmoc groups were removed by washing with 20% piperidine in 
DMF while shaking for 20 min. The desired amino acids were coupled using 3 eq Fmoc-protected 
amino acid, 3.3 eq diisopropylcarbodiimide and 3.6 eq N-hydroxy benzotriazole for 40 min up to 
overnight as indicated by a negative Kaiser test.36 After final Fmoc removal, the resin was washed 
with DMF, dichloromethane and methanol and dried. Cleavage from the resin was performed 
using 90% trifluoroacetic acid, 5% water, 2.5% triisopropylsilane and 2.5% thioanisole for 5 
hours. After filtration from the resin the free peptide was precipitated in diethyl ether, dried in 
air, redissolved in water and lyophilized. LCMS was performed on a Thermo Finnigan LCQ-Fleet 
ESI-ion trap (Thermo Fischer, Breda, The Netherlands) equipped with Alltima C18 column, 2.1 x 
150 mm, particle size 3 µm (Alltech Applied Sciences, Breda, Netherlands) using an acetonitrile/
water gradient with 0.1% formic acid.
Chip preparation
SensEye Au iSPR sensors (Ssens, Enschede, The Netherlands) were cleaned by incubation for 10 
min with a 3 : 1 solution of sulphuric acid (analysis grade, 95-97%) and 30% hydrogen peroxide. 
Following incubation the chip was rinsed with Milli-Q water, ethanol and dried under nitrogen. 
The surface was subsequently coated with a peptide layer by overnight incubation with a mix-
ture of 4.75 mM anti-fouling peptide (MPA-LHDLHD) and 0.25 mM leucine zipper-anti-fouling 
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fusion peptide (RE: MPA-LHDLHDLEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETRYGPLGG
GGK or ER: MPA-LHDLHDLEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGGGGK ) in 
Milli-Q water. After incubation the chip was rinsed thoroughly with Milli-Q. 
Protein immobilization
Immobilization of purified, zipper-tagged La to the peptide surface was achieved by incubation 
with 150 ng/mL of the protein in PBS containing 0.075% Tween-80 during 1h in a Continuous 
Flow Microspotter (Wasatch Microfluidics, Salt Lake City, UT, USA), equipped with a printhead 
for up to 48 spots of approximately 0.1 mm2 each. This incubation was followed by a 2 min 
washing step. For immobilization of zipper-tagged La using crude bacterial lysates, Tween-20 
was added to a final concentration of 0.1% vol. before similar incubation in the microspotter. 
Covalent immobilization to the peptide-surface was performed by activation for 30 min with 50 
mM 1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide and 250 mM sulfo-(N-hydroxy-succinim-
ide) (NHS) in 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) followed by 1h incubation with 
150 ng/mL non-tagged La protein in sodium acetate pH 4.5.
iSPR analysis
Performance of the peptide anti-fouling layer was tested by preparing a chip as described under 
chip preparation. For comparison a SensEye Easy2Spot-P (Ssens, Enschede, The Netherlands) 
chip with planar NHS ester functionality was used and blocked by incubation for 10 min with 
a 1 M 2-aminoethanol solution in 10 mM MES pH 5.5. For analysis of the non-specific binding 
to these surfaces, zipper-tagged La and serum proteins were diluted in system buffer (PBS con-
taining 0.075% Tween-80) to final concentrations of 100 μg/mL. Binding of these proteins was 
visualized in an IBIS MX96 iSPR over a period of 30 min and analysed using SPRintX software 
(IBIS Technologies, Enschede, The Netherlands) by equalization of baselines and determination 
of the response at the end of the binding phase.  
Immobilization of the leucine zipper-tagged protein was visualized by preparation of the 
anti-fouling layer as described under chip preparation, followed by 30 min incubation in the IBIS 
MX96 iSPR with 60, 12 and 6 µg/mL zipper-tagged La in system buffer, 8 min buffer wash and 1 
min regeneration with 6 M guadinine-HCl.  Analysis was performed with SPRintX software and 
baselines equalized.
Visualization of the immobilized leucine zipper-tagged proteins using antibodies was per-
formed by preparation of a leucine-zipper functionalized chip as described under chip prepa-
ration. After immobilization of either the purified proteins or the proteins from crude lysate, 
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the first measurement and regeneration cycle was performed with system buffer (in case of 
purified proteins) or with 1 M NaCl (in case of the crude lysate). Binding of monoclonal anti-
body (a 1:20 dilution of culture supernatant containing 5% serum in system buffer, resulting 
in approximately 1 µg/mL antibody according to SDS-PAGE analysis) was visualised in the IBIS 
MX96 iSPR for 40 min, followed by 8 min dissociation and 1 min regeneration with 10 mM gly-
cine-HCl, pH 2.0, unless stated otherwise. Analysis was performed with SPRintX software; the 
chip surface was calibrated according to the manufacturer’s instructions, baselines were equal-
ized and the response was determined at the end of the binding phase, when binding was close 
to equilibrium. 
Statistical analyses
Significance of the differences in protein-binding to the antifouling layers and of the anti-
body-binding to the La protein immobilized using a leucine zipper tag or using covalent cou-
pling was assessed using an unpaired, one-way ANOVA with Tukey-test. Significance between 
the responses from antibody-binding to leucine zipper-tagged and untagged protein pairs 
immobilized from crude lysate was assessed using a t-test. All statistical analyses were per-
formed using Graphpad Prism 5 (Graphpad Software, La Jolla, CA, USA).
3.3. Results and Discussion
Peptide-based self-assembled monolayer for antifouling
The gold surface of an iSPR chip is typically covered with either a dextran hydro-
gel or a monolayer of carboxyl-terminated alkane thiols to avoid non-specific inter-
actions with the gold and to provide functional groups for immobilization. Good 
results have also been reported with zwitterionic polymers.37,38 More recently, 
Masson and co-workers developed monolayers of various zwitterionic peptides with 
an N-terminal 3-mercaptopropionic acid (MPA) for surface attachment,39,40 which 
provide a similar function. For our purpose, we selected the anti-fouling peptide 
consisting of MPA – Leu – His – Asp – Leu – His – Asp, which showed good anti-foul-
ing properties with serum as analyte solution.19 This peptide was synthesized using 
Fmoc solid-phase peptide synthesis and its integrity and purity were confirmed with 
LC-MS (Supplementary Figure 3.9). 
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In order to assess anti-fouling performance, non-specific binding to the gold surface 
of an iSPR sensor coated with the anti-fouling peptide was investigated by exposing 
the coated surface to high concentrations of either a purified recombinant protein 
or a crude biological sample (serum). The coated surface was incubated with a high 
concentration, 100 µg/mL, of leucine zipper-tagged La protein, a putative RNA chap-
erone which is a target for autoantibodies in patients with systemic lupus erythe-
matosus and Sjögren’s syndrome,41 or with a similar concentration of bovine serum 
proteins in PBS containing 0.075% Tween-80. Serum proteins were chosen because 
they were also present during subsequent antibody binding experiments (see below). 
The non-specific binding to the peptide layer was compared with binding to a com-
parable, commercially available alternative with a planar, NHS ester-functionalised 
surface chemistry blocked with 2-aminoethanol. 
After incubation with the purified protein solution for 30 minutes, non-specific 
binding to the iSPR chip was approximately equal for both tested layers, while after 
incubation with the serum proteins a considerably lower non-specific binding was 
observed with the peptide layer (Figure 3.2). These results showed that the pep-
tide-based layer has indeed good anti-fouling properties which are particularly use-
ful for measuring antibody interactions.
Leucine zipper based immobilisation for iSPR
To provide stable immobilization, a leucine zipper pair with high affinity, yet low homodi-
merization properties is desired. Such a pair was previously described by Moll and cow-
orkers (peptide RE: LEIRAAFLRQRNTALRTEVAELEQEVQRLENEVSQYETRYGPLGGGGK 
and peptide ER: LEIEAAFLERENTALETRVAELRQRVQRLRNRVSQYRTRYGPLGGGGK).31 
Figure 3.2: Anti-fouling properties of zwitterionic peptide 
monolayer. The response due to non-specific binding to the 
peptide monolayer is compared with a commercially available 
chip with planar, NHS ester-functionalised surface chemistry 
that was blocked using 2-aminoethanol. Analytes were 100 
μg/mL zipper-tagged La protein and approximately 100 μg/
mL serum proteins in PBS containing 0.075% Tween-80. Bars 
represent the mean with standard deviation of triplicate anal-
yses. Significance of differences (***: P ≤ 0.001; ns: non-signif-
icant) was assessed using a one-way ANOVA with Tukey test. 
RU: response units.
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Both leucine zipper peptides were synthesized with the anti-fouling sequence and 
3-mercaptopropionic acid at the N-terminus (Supplementary Figure 3.10 and 3.11). 
This allowed the attachment of either peptide to the gold surface of an iSPR sensor, 
with the leucine zipper peptide protruding from the monolayer of anti-fouling pep-
tides (Figure 3.1). A 20-fold molar excess of anti-fouling peptide compared to leucine 
zipper peptide was used to create an anti-fouling layer which will yield a high den-
sity of immobilized leucine zipper molecules.
The cloning of sequences coding for a target protein fused to a leucine zipper was per-
formed with the Gateway system,42 which allows efficient transfer of DNA-fragments 
between plasmids by recombination cloning.  To facilitate high-throughput cloning 
of zipper-fusion constructs, the pDEST17 vector of the Gateway system was modified 
by the incorporation of either the ER
 
or the RE sequence. This resulted in the pDNz-
VinER and pDNz-VinRE plasmids (see Supplementary Figures 3.7, 3.8 and Table 3.1), 
which after incubation with the recombination enzyme mix and the pENTR vector 
containing the cDNA of the target La protein, led to the desired leucine zipper fusion 
expression construct. The constructs for the ER- and RE-tagged La protein obtained 
this way, were expressed in E. coli using standard techniques (Supplementary Figure 
3.12). After purification, the recovered yield of soluble fusion protein was somewhat 
lower compared to the unmodified La protein (data not shown), which might be due 
to an increased tendency of the tagged protein to aggregate.
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Figure 3.3: Leucine zipper-based immobilization of the La protein on an iSPR surface. a) Sensorgram 
visualizing binding of 60, 12 and 6 µg/mL of zipper-tagged La protein to the complementary zipper 
peptide on the iSPR surface. Binding was performed in PBS containing 0.075% Tween-80 for 4500 s, 
after which dissociation conditions (buffer wash) were applied for 1500 s. b) Sensorgram visualizing 
binding of 1 µg/mL anti-La monoclonal antibody SW5 to the immobilized La protein, tagged with a 
leucine zipper complementary (ER) or non-complementary (RE) to the sensor surface. Binding was 
performed in PBS containing 0.075% Tween-80 for 2400 s, after which dissociation conditions (buffer 
wash) were applied for 480 s. Non-specific binding signals to reference areas of the surface are indi-
cated by the dashed line. RU: response units.
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To immobilize the fusion protein, the leucine zipper-functionalised surface was incu-
bated with the purified fusion protein containing a complementary zipper sequence 
and the immobilization was monitored by iSPR (Supplementary Figure 3.13). The 
resulting sensorgram (Figure 3.3a) shows swift association of the fusion protein and 
very slow dissociation during a buffer wash, reflecting the very stable non-covalent 
interaction. Consequently, dissociation was negligible during the timeframe of SPR 
measurements.
Using a continuous flow microspotter with an array of microfluidics flow cells, indi-
vidual ‘spots’ on a sensor chip were incubated with either fusion proteins with com-
plementary and non-complementary zipper sequences to assess the specificity of 
immobilization. A traditional activated ester coupling was performed in parallel to 
compare leucine zipper-based with covalent immobilization. The entire sensor chip 
was incubated with antibodies against the La protein, to visualize the immobilized 
proteins (Figure 3.3b, Figure 3.4, Supplementary Figure 3.14). The complementary 
zipper-tagged La protein indeed was efficiently immobilized on the surface, whereas 
the antibody-binding signals for the non-complementary zipper-tagged protein 
were hardly detectable, indicating that the latter was not, or only very inefficiently, 
a)                                                       b)
Figure 3.4: Specificity of leucine zipper-based immobilization detected by antibody binding. a) Zipper-
tagged La protein was immobilized on a RE leucine zipper-functionalized sensor surface using, from 
left to right, a complementary (ER) leucine zipper-tag, activated-ester mediated covalent coupling 
and a non-complementary (RE) leucine zipper tag. b) Maximum iSPR responses for anti-La antibody 
binding to the immobilized La protein. Bars represent the mean of triplicate analyses with standard 
deviation for 1 µg/mL anti-La monoclonal antibody SW5 binding in PBS containing 0.075% Tween-80. 
Significance of differences (**: P ≤ 0.01, ***: P ≤ 0.001) was assessed using a one-way ANOVA with 
Tukey test. RU: response units.
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immobilized. This substantiates the specificity of zipper-based immobilization. 
Antibody-binding to zipper-immobilized protein was higher than when the protein 
was covalently bound to the surface. These observations reflect those of previous 
reports6,43 that site-specific protein immobilization improves the binding response. 
With site-specific immobilization the protein structure is better preserved, resulting 
in less non-binding protein molecules on the surface. Also the accessibility of bind-
ing sites for the antibodies might have been improved due to a more favourable ori-
entation of the immobilized protein. In addition, it should be noted that we can not 
exclude the possibility that covalent immobilization led to a lower amount of protein 
immobilized on the surface compared to the zipper-mediated immobilization.
For multiple binding experiments on a single chip it is important that the immo-
bilized proteins are resistant to regeneration procedures. In typical SPR measure-
ments the ligand is immobilized on the surface once and after a binding experiment, 
the bound analyte is removed from the surface by a regeneration step, allowing the 
next binding experiment. For bound antibodies this regeneration step is commonly 
performed by a short incubation with a low pH solution.44 For optimal regenera-
tion the maximum response should remain constant over multiple measurement 
cycles. With a relatively harsh treatment at pH 1.3 the maximum response for the 
binding of anti-La antibody to the zipper-La protein showed a clear reduction, with 
a total decrease after 4 cycles of approximately 20%, most likely due to detachment 
or denaturation of the immobilized protein (Figure 3.5). However, under somewhat 
milder regeneration conditions (pH 2.0) the response remained stable and the total 
decrease after 4 cycles was less than 5%. These data indicate that it is possible to 
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Figure 3.5: Relative response of antibody-binding after 
consecutive regeneration cycles. Each cycle consisted 
of incubation with antibodies, followed by regenera-
tion with 10 mM glycine-HCl of pH 1.3 or pH 2.0. The 
mean is shown with standard deviation of triplicate 
analyses with 1 µg/mL anti-La monoclonal antibody 
SW5 in PBS containing 0.075% Tween-80.
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selectively remove the bound antibody from the surface, while the immobilized pro-
teins remain intact and available for binding during several consecutive measure-
ments and surface regenerations.
Although the immobilization of proteins is simplified by using the leucine zip-
per-mediated approach, the laborious fusion protein expression and purification 
steps still remain. To reduce the amount of work involved, the specificity of leucine 
zipper-binding can also be employed to immobilize fusion proteins directly from 
crude bacterial lysates. Besides the previously used La protein, a second autoan-
tigenic protein was used, U1A, a protein component of the U1 small nuclear ribo-
nucleoprotein particle.41 The lysates of both fusion proteins were first cleared from 
insoluble material and bacterial DNA by two centrifugation steps and precipitation 
using poly(iminoethylene). The cleared lysates were then applied to the zipper-func-
tionalized surface and after incubation the surface was rinsed thoroughly to remove 
non-bound material. Immobilized proteins were visualized by measuring antibody 
binding using iSPR. The results in Figure 3.6 show that the leucine zipper-tagged U1A 
and La proteins were indeed immobilized by binding to the complementary zipper 
peptides, while untagged proteins were largely washed away, demonstrating that 
crude cell lysates can be employed for leucine zipper-based ligand immobilization. 
While leucine zipper-based immobilization is potentially widely applicable, the leu-
cine zipper sequence, although shorter than the previously mentioned SNARE com-
plex33, is relatively long compared to the moieties used for the execution of covalent 
coupling strategies. This might be a disadvantage in experiments where the length 
of this element is of importance. Additionally, the incorporation of a sequence of this 
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Figure 3.6: Immobilization of leucine zipper-tagged proteins 
from crude bacterial lysates. Antibody-binding response to 
spots incubated with crude cell lysates containing fusion 
proteins with complementary (RE-tagged protein on ER 
surface and vice-versa) zipper sequences and untagged 
proteins, on a surface functionalized with the ER peptide 
(black/white) and the RE peptide (grey/white). The bars 
represent the mean of triplicate analyses with standard 
deviations for 1 µg/mL anti-La monoclonal antibody SW5 
and anti-U1A monoclonal antibody 9A9 in PBS containing 
0.075% Tween-80. Significance of differences (**: P ≤ 0.01, 
***: P ≤ 0.001) between tagged and untagged protein pairs 
was assessed using a t-test.
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length increases the risk that it interferes with proper protein folding or that steric 
effects influence the accessibility of important regions of the protein. Like other 
techniques which rely on fused peptide tags, such as a sortase- or ybbR-tags,14,15 
this potentially limits the available orientations in which a protein can be immobi-
lized and may restrict applications particularly to proteins with free N- or C- termini. 
In contrast to covalent immobilization strategies, the non-covalent nature of the 
leucine zipper-tags provides an opportunity to regenerate a biosensor surface for 
the analysis of unrelated biomolecular interactions by denaturing the coiled-coil 
structure.
3.4. Conclusions
We have demonstrated that leucine zippers as fusion tags can successfully be used 
as an integrated system for well-controlled, site-specific immobilization of pro-
teins on surfaces, e.g. for SPR analysis.  A peptide-based anti-fouling layer on the 
bare gold surface of an iSPR chip allows functionalization of the surface with leu-
cine zippers, without additional coupling or capturing steps and with comparable 
anti-fouling performance to commercially available alternatives. Two model pro-
teins were genetically fused to a leucine zipper sequence using a high-throughput 
cloning procedure, and effectively immobilized on such a surface by leucine zip-
per heterodimerization. Availability of the immobilized proteins was subsequently 
assessed by incubation with antibodies, where the antibody binding response for 
protein immobilized using leucine zippers was higher than that observed for a clas-
sical, random, activated ester-based coupling strategy. Although non-covalent and 
reversible, leucine zipper-based immobilization was stable in the time-frame of SPR 
measurements and not affected by regeneration conditions commonly used in anti-
body-based assays. This way of immobilization does not necessarily require purifica-
tion of tagged proteins from crude cell lysates, further reducing the time and effort 
involved in immobilization. The minimal number of intermediate steps in the immo-
bilization procedure minimizes the risk for undesired heterogeneity on the surface. 
The compatibility with high-throughput procedures and the simple incubation steps 
make leucine-zipper mediated immobilization ideally suited for applications which 
involve a multitude of proteins to be analysed, like multiplex iSPR.
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3.5. Supplementary Figures
Figure 3.7: Vector map and zipper sequence of pDNz-VinER.
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Figure 3.8: Vector map and sequence of pDNz-VinRE.
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Figure 3.9: High performance liquid chromatography (Ch1: 214 nm, Ch2: 254 nm) and electron spray 
mass spectrometry of MPA-LHDLHD. Calculated mass: 836.84 ([M+H]1+ 837.48, [M+2H]2+ 419.28).
Figure 3.10: High performance liquid chromatography (Ch1: 214 nm) and electron spray mass spec-
trometry of ER leucine zipper peptide. Calculated mass: 6370.14 ([M+5H]5+ 1274.76, [M+6H]6+ 
1062.68, [M+7H]7+ 911.08, [M+8H]8+ 797.28, [M+9H]9+ 708.72).
Figure 3.11: High performance liquid chromatography (Ch1: 214 nm) and electron spray mass spec-
trometry of RE leucine zipper peptide. Calculated mass: 6287.94 ([M+5H]5+ 1258.52, [M+6H]6+ 
1048.92, [M+7H]7+ 899.36).
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Figure 3.12: SDS-PAGE with coomassie brilliant blue protein stain of leucine zipper-tagged La solu-
tions and lysates containing leucine zipper-tagged La and U1A proteins.
Figure 3.13: Example of a view through the iSPR camera. Three microarray-spots, part of the meas-
urements depicted in figure 4b, are visible with regions of interest defined in red (1: RE-La, 2: covalent, 
3: ER-La) and adjacent reference regions in green.
Figure 3.14: Sensorgram visualizing binding of 0.4 µg/mL anti-La monoclonal antibody SW5 to the La 
protein, tagged with a leucine zipper complementary (ER) or non-complementary (RE) to the sensor 
surface, immobilized using various concentrations. Binding was performed in PBS containing 0.075% 
Tween-80 for 1800 s, after which dissociation conditions (buffer wash) were applied for 480 s. Non-
specific binding signals to reference areas of the surface were subtracted. RU: response units.
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We have all heard of the puzzle given to Archimedes…. His finding 
that the crown was of gold was a discovery; but he invented the method 
of determining the density of solids. Indeed, discoverers must gener-
ally be inventors; though inventors are not necessarily discoverers.
Sir William Ramsay, chemist 
How Discoveries Are Made, 1908
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Detection of anti-citrullinated protein antibodies (ACPA) is a valuable diagnostic and predictive tool in management of rheumatoid arthritis. The heterogeneous 
mixture of targets recognized by ACPA allows profiling of sub-specificities to obtain 
putative relations between epitopes and disease progression. We used previously 
described multiplex surface plasmon resonance imaging techniques to screen reac-
tivity against 43 molecules for a wider assessment of ACPA fine-specificities. To elim-
inate the potential influence of the efficiency of peptide immobilisation on the chip 
and the dependence on antibody concentration and affinity, a method was devel-
oped to determine antibody titers based on binding kinetics under mass transport 
limited conditions. This new analysis method improved reproducibility by reducing 
variance from peptide immobilisation and enhanced the efficiency by shortening the 
incubation times.
4.1. Introduction
Rheumatoid arthritis (RA) is an autoimmune disease characterised by chronic joint 
inflammation. A large number of patients are positive for so-called ACPA, which are 
autoantibodies against epitopes in proteins or protein fragments containing an argi-
nine that has been deiminated post-translationally to form a citrulline.1 Detection 
of these ACPA is a valuable diagnostic and predictive tool for RA and ACPA are also 
associated with progression of the disease.2 These biomarkers are generally detected 
by enzyme-linked immunosorbent assays, using cyclic citrullinated peptides (CCP) as 
binding ligands for ACPA. While originally derived from the sequence of citrullinated 
filaggrin,3 these cyclic peptides have been optimized to allow recognition of ACPA 
with different subspecificities from different RA patients.
While a CCP interacts with a wide collection of ACPA, ACPA themselves are not 
homogeneous. In patient sera, ACPA against a variety of citrullinated epitopes 
from different proteins have been reported.4 This has led to studies to investigate 
whether ACPA subspecificities are correlated with specific ways of disease progres-
sion or with specific risk factors, so far with mixed results. For a small set of epi-
topes a relation between ACPA epitope spreading and disease progression has been 
found, but no clear correlations with ACPA against specific epitopes were found.5–8 
Modern multiplex detection techniques have made it practical to screen for reac-
tivity against multiple epitopes simultaneously, allowing wider assessment of ACPA 
fine-specificities.9–13
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RA is a highly multi-factorial disease, influenced by environmental as well as genetic 
factors. Remarkably, RA population studies show that there are noticeable differ-
ences in prevalence correlated with patient background.14–16 These observations 
suggest that the risk for developing RA is affected by the ethnic or geographic back-
ground of patients. Up to now, some investigations that try to link geographical vari-
ations with genetic risk factors have been performed, but these have not yet resulted 
in a clear explanation for observed differences.17,18 The ACPA fine-specificity profile 
could make it possible to obtain more insight in the relation between such risk fac-
tors and the observed immune process. In order to demonstrate such influences, the 
profiling method needs both a wide set of presented antigens, to acquire a detailed 
profile, and a high reproducibility, as high variations in the data will obscure smaller 
differences. 
To improve profiling of ACPA fine-specificity in RA sera, we have expanded a pre-
viously used collection of antigenic peptides for ACPA screening to obtain more 
detailed profiles.10 Additionally, because the previously used multiplex surface plas-
mon resonance assay (iSPR) was based on equilibrium binding of ACPA to antigenic 
peptides, and appeared to be highly dependent on the efficiency of peptide immobil-
isation and antibody affinity, we developed an improved analysis method. By using 
the real-time capabilities of SPR, a proxy for antibody titers based on binding rates 
was able to achieve more reproducible readouts in a much smaller period of time. 
4.2. Materials & Methods
Equilibrium binding for peptide selection
Equilibrium binding of ACPA to peptide epitopes was measured by SPR similar to the procedure 
described before.10 Briefly, biotinylated peptides (see Table 4.1) were synthesized by performing 
a solid-phase procedure using 9-fluorenylmethyloxycarbonyl chemistry.19 The peptides were at 
least 90% pure, as deduced from their elution pattern on reverse-phase high-performance liq-
uid chromatography. Prior to immobilisation a 1 mg/mL stock solution in ddH2O with 5% vol. 
DMSO was diluted to 2 µg/mL in PBS with 0.075% vol. Tween-80 (PBSt). Twenty distinct bioti-
nylated and citrullinated peptides per chip were immobilized on a SensEye Strep-G iSPR chip 
(Ssens, Enschede, The Netherlands), functionalized with a high-density streptavidin hydrogel, 
by incubation in a continuous flow microspotter (Wasatch Microfluidics, Salt Lake City, UT, USA) 
for 1 h. 
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Table 4.1: Peptides with putative ACPA epitopes and their origin.
nr Sequence Origin Citrulline(a)
1 TSSTSYNXGDSTFZO fibrinogen α591
2 EEAPSLXPAPPPISGGGYXAXPAKAAAZO fibrinogen β60;72;74
3 FLAEGGGVXGPRVVERHZO fibrinogen α35
4 NEEGFFSAXGHRPLDKKZO fibrinogen β44
5 SLNLXETNLDSLPLVDZO vimentin 424
6 MSTXSVSSSSYXXMFGGPZO vimentin 4;12;13
7 GVYATXSSAVXLXSSVPGZO vimentin 64;69;71
8 CKIHAXEIFDSXGNPTVECZO α-enolase 9;15
9 GLPGVKGHXGYPGLDGAZO collagen type II 290
10 (b) CCP2-like n/a
11 HQCESTXGRSRGRCGRSGSZO CCP1-like n/a
12 XRXYLYXYRSLXZO synthetic n/a
13 TKVFIVXQTRRHFZO synthetic n/a
14 RATRKHXKLYLFYCZO synthetic n/a
15 RNYVYXSXIRKZO synthetic n/a
16 LTVGLTXXGQPRQYZO fibronectin 1035;1036
17 YNQYSQXYHQRTNZO fibronectin 2356
18 KLTSEAXGXIPVAQKZO MNDA 127;129
19 MKILTEXGYSFTTAEXEIVXDIKEKLZO β-actin 196;206;210
20 LTAALXDVXQQYESZO vimentin 270;273
21 VYATXSSAVXLXSSVPZO vimentin 64;69;71
22 AVAASKEXSGVSLAAZO histone H1 53
23 SGXGKQGGKARZO histone H2A 3
24 RIAGEASXLAHTNKRZO histone H2B 79
25 AXTKQTAXKSTGGKZO histone H3 2;8
26 KAPXKQLATKAAXKSAPSTZO histone H3 17;26
27 SGXGKGGKGLGKZO histone H4 3
28 KRHRKVLXDNIQGITZO histone H4 23
29 LNGAKGWLXDPSASPGDZO vinculin 285
30 TAPPDAPNXEEVFDERZO vinculin 622
31 KSFLDSGYXILGAVAKVZO vinculin 823
32 FGPVINGXCCLEEKVZO PAD4 609
33 OMDHAXHGFLPXHXDTGILDS myelin basic protein 159;165;167
34 OXHXDTGILDSIGXFFGGDXG myelin basic protein 34;44;50
35 OIGXFFGGDXGAPKXGSGKDS myelin basic protein 44;50;55
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The chip, containing an array of immobilized peptides, was analysed in an IBIS MX96 iSPR instru-
ment (IBIS Technologies, Enschede, The Netherlands) for binding by ACPA from 30 early RA 
sera,20,21  along with a positive control serum and a mixture of two monoclonal ACPA (ModiQuest, 
Oss, The Netherlands). Each binding cycle consisted of a 1 min incubation with PBSt (baseline), 
40 min interaction with diluted serum (1:50 in PBSt) under a continuous back-and-forth flow at 
50 µl/s, followed by 8 min of dissociation in PBSt and removal of the remaining bound material 
by a 1 min injection with 10 mM glycine-HCl, pH 2.0. Each analysis cycle started with a blank PBSt 
sample to stabilize the chip and instrument.
Binding response was analysed using SprintX (IBIS Technologies, Enschede, The Netherlands) 
by subtracting binding to blank reference areas on the surface and normalizing the baselines. 
The binding response was measured upon stabilisation of the signal after the start of the disso-
ciation phase, eliminating very weak non-specific binding and bulk effects from the change in 
solution. The results were split between sera that were ACPA-positive and ACPA-negative based 
on the Immunoscan CCPlus enzyme-linked immunosorbent assay (Euro-Diagnostica, Malmö, 
Sweden).
36 OAPKXGSGKDSHHPAXTAHYG myelin basic protein 55;66
37 OKNIVTPXTPPPSQGKGXGLS myelin basic protein 124;134
38 OLSXFSWGAEGQXPGFGYGGX myelin basic protein 140;149
39 OQXPGFGYGGXASDYKSAHKG myelin basic protein 149;157
40 OSKIFKLGGXDSXSGSPMAXX myelin basic protein 187;190
41 OZCHFSXASSCIDELFQDXFFTX-CONH2 clusterin 235;247;251
42 OZAXLKSWFEPLVEDMQXQWAGC-CONH2 apolipoprotein E 278;292
43 OZCEDLLXYSKLYXLGCGHNQIX-CONH2 biglycan 251;257
Peptides selected for profiling are marked in bold.  
(a) = Amino acid position in the polypeptide chain, relative to the N-terminus. α or β prefix 
indicates α- or β-chain of fibrinogen. 
(b) = Sequence as defined in patent EP2071335   
CCP = cyclic citrullinated peptide30 
PAD = peptidylarginine deiminase  
MNDA = myeloid cell nuclear differentiation antigen 
n/a = not applicable 
O = biotinyl-lysine 
X = citrulline 
Z = aminohexanoic acid
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Conditions for binding rate analysis
Immobilisation of the peptides was achieved as described above, with either 2, 20 or 200 µg/
mL solutions in PBSt. Analysis in the IBIS MX96 iSPR was performed using an ACPA-positive con-
trol serum (KC64) and an analysis cycle of a 1 min baseline PBSt incubation, followed by 8 min 
binding phase at 10 or 50 µl/s back-and-forth flow and 1 min dissociation for each of the serum 
dilutions (either 1:2700, 1:900, 1:300 and 1:100, or 1:450, 1:150 and 1:50) in PBSt. After this series, 
the chip surface was regenerated with a 1 min injection with 10 mM glycine-HCl, pH 2.0.
The binding rate was obtained by subtracting the reference-binding (binding to blank reference 
areas on the chip) and normalizing the baselines in SprintX, followed by a linear regression over 
the first 60 s of each binding phase. These resulting rates were normalised to the serum dilution 
by dividing by the corresponding dilution factor (ie. divided by 1/450th, 1/150th and 1/50th).
Reproducibility assays
Twenty peptides were immobilized as described above using a 20 µg/mL dilution in PBSt. 
Comparison of KC64 control serum was performed using two subsequent analysis cycles with 
a 1 min baseline incubation, 8 min binding phase at 10 µl/s and 1 min dissociation for 1:450, 
1:150 and 1:50 serial dilutions. Following the three dilutions, the surface was regenerated for 1 
min with 10 mM glycine-HCl, pH 2.0 before the next analysis cycle. For analysis of chip-to-chip 
variability, immobilisation was performed on a second chip and analysed with fresh dilutions. 
To assess stability during regeneration cycles, the KC64 control serum was interleaved five times 
with 26 other sera in one measurement session. After a period of a few hours to reset the instru-
mentation and prepare new serum dilutions, a similar session was run, yielding a comparison 
for 64 subsequent cycles on one chip. All measurement sessions were preceded by a single PBSt 
incubation to stabilize the system.
Binding rates were obtained after subtracting binding to a reference surface and normalization 
of the baselines in SprintX by linear regression from the injection to 60s after injection time 
(binding phase). The rates normalised to the serum dilution and the mean of either the 1:450 
and 1:150, or 1:150 and 1:50 dilutions, whichever highest, was used as result.
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4.3. Results and Discussion
Assay improvements
Previous research of ACPA fine-specificity using SPR involved the analysis of reac-
tivity to twenty citrullinated peptides.10 We developed an improved profiling assay 
based on those results, which involved both the composition of the peptide array 
and the encountered variation. 
First, several of the original peptides were non-reactive or only reactive with sera 
from a very small number of patients. To obtain more extensive information about 
ACPA fine-specificity, the poorly reactive peptides were replaced with more fre-
quently reactive peptides. Based on previously reported ACPA targeting sites, the 
initial set of twenty peptides was expanded to forty three molecules containing puta-
tive ACPA epitopes (listed in Table 4.1).22–25 To assess the reactivity with ACPA-positive 
RA sera in an iSPR setting, synthetic biotinylated peptides containing these putative 
epitopes were immobilized on streptavidin-coated SPR chips (containing up to 20 
different peptides each). After immobilisation, the peptides were consecutively incu-
bated with a random set of 31 RA patient sera and a mixture of 2 monoclonal ACPA, 
and in each case the (near-)equilibrium binding levels of the antibodies were mea-
sured (Figure 4.1). Based on response level and frequency of positive response, pep-
tides were classified as not, moderately (non-zero response) or highly reactive (above 
~1500 RU) with ACPA-positive sera. Peptides classified as highly reactive, or classified 
moderately reactive with no reactivity to ACPA-negative sera, were selected to com-
pose the profiling set. Furthermore, peptides which were not reactive in our assay, 
but were used successfully in other assays were also selected. In total a profiling 
set containing 20 peptides was selected (bold in Table 4.1). Compared to the origi-
nal set, this set contained new peptides derived from histone H2A and H4, vinculin, 
two regions of myelin basic protein and clusterin (peptides 23, 27, 29, 37, 39 and 41). 
These peptides replaced those peptides from fibrinogen, vimentin and fibronectin 
that appeared to be poorly reactive with RA sera, and some non-protein-derived 
peptides that were selected by random peptide library screening. 
Second, due to the number of sera required for effective profiling, the reproducibility 
of measurements on multiple SPR-chips should be high. In this respect, it is important 
to note that the total number of sera that can be analysed on a single chip is limited, 
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most often because regeneration of the array after each serum incubation slightly 
decreases the quality of the chip. The variation of measurements with distinct chips 
was determined by the analysis of the positive controls (KC64 patient serum, mono-
clonal ACPA antibodies) on four SPR-chips using the equilibrium response method 
and the results showed a relatively high level of variation (coefficient of variation 
27-70%; Figure 4.2).
Equilibrium response vs binding rate measurements
Although determining equilibrium binding levels yields a direct indication of the 
reactivity of patient sera with the citrullinated peptides on the array, without exten-
sive data processing, and while the output is similar to standard ELISA-based assays, 
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Figure 4.1: Antibody binding levels to peptides with possible ACPA epitopes from known ACPA-
positive (black diamonds) and ACPA-negative RA-sera (grey diamonds) measured by SPR. Depicted 
are near-equilibrium responses of 31 RA-sera to a) peptides 1 to 20 obtained from an earlier set10 and 
b) peptides 21 to 43 newly selected from published literature. *: peptide selected for profiling array. 
RU: response units.
71optimisation of profiling anti-citrullinated protein antiBodies in rheumatoid arthritis By multiplex  
spr
it has several disadvantages. First, to achieve near-equilibrium levels the time 
required for the analysis of one patient sample is at least 40 minutes, which makes 
the analysis of many patient samples rather time consuming.10 Second, the outcome 
depends on both antibody concentration and affinity, which may be rather different 
among ACPA in patient sera. The dependence on concentration and affinity is illus-
trated by the rate equation: the response level over time of a simple SPR association 
phase can be described by
with R
max
 the maximum achievable binding response, [A] the antibody concentration, 
K
D
 the dissociation constant, k
a
 the association rate constant and k
d
 the dissociation 
rate constant. 
∙
 ∙  ∙                  4.1  
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Figure 4.2: Reproducibility of equilibrium binding responses over multiple, sequentially measured SPR-
chips. For comparison, response against peptide 10 and 11 with the positive controls (a single ACPA-
positive reference serum and a mix of ACPA-monoclonal antibodies , ‘monoclonals’) is displayed. 
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From this follows the equilibrium binding level (t → ∞):
This clearly shows dependence on both concentration and affinity. Finally, the 
amount of antibody that can be bound, R
max
 in equations 4.1 and 4.2, is largely deter-
mined by the amount of peptide on the surface. This means that the equilibrium 
binding levels are highly dependent on the amount of peptide available on the sur-
face for binding. The multiplex SPR format with peptide microarrays, however, has 
a high risk of introducing variation in the peptide immobilisation. The small scale of 
the flow cells of the microspotter in combination with the microfluidic flow system 
make it difficult to achieve a very even, equal flow in all cells, necessary for a highly 
reproducible immobilisation. Furthermore, it is difficult to get insight in the hetero-
geneity between the spots, because, unlike immobilisation with a traditional SPR-
instrument, immobilisation with a microspotter does not allow direct monitoring of 
the immobilisation level. 
Instead of relying on the equilibrium binding response, the ability of the SPR tech-
nology to analyse the binding rates can be used to develop an alternative quantifi-
cation method that is not or less strongly affected by antibody affinity and peptide 
availability. The concentration of active biomarkers in serum can be determined 
by analysis of the binding rate under conditions that are mass transport limited.26,27 
Under such conditions, the diffusion rate of analyte molecules through the medium 
is limiting the association rate. At the start of the binding phase, where the amount 
of previously bound analyte is negligible, the binding rate can be described by
where R is the binding response, L
m
 the diffusion rate between the bulk of the solu-
tion and the surface and G a constant describing the response level achieved for an 
amount of bound analyte on a surface area.27,28 If (k
a
 · R
max
) is much larger than L
m
, 
which means the interaction is fully mass transport limited, the formula is simplified 
to 
∙ ∙
∙
 ∙   
∙   
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If the diffusion rate is constant, this means that the observed association rate will be 
linearly dependent on the concentration of analyte. Thus the binding rate at the start 
of the binding phase can be used as a measure for analyte concentration, indepen-
dent of peptide immobilisation levels.
Conditions for binding rate analysis
For the binding rate analysis, two conditions are crucial: a maximal amount of 
immobilized peptide to create an as large as possible R
max,
 and an optimal analyte 
concentration, which should be sufficiently low to have a limited mass transport, 
but still give sufficient response levels to allow accurate measurements. The optimal 
analyte concentration can be tuned by adjusting the serum dilution. To determine 
which conditions are optimal for the ACPA profiling assay, the binding rate of a dilu-
tion series of ACPA (patient serum) to three peptides was analysed. The sensorgrams 
Figure 4.3: Binding-rate-based concentration analysis of ACPA in RA serum. a) Sensorgram of 4 sub-
sequent injections with increasing concentrations of an ACPA-positive RA serum for peptide 10, 
which was immobilized by incubation with 2, 20 or 200 µg/mL of peptide. b) Binding rate to peptide 
10, 11 and 16 during the first 60 s of binding, normalised to serum dilution.
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in Figure 4.3a show the effect of the amount of peptide used during immobilisa-
tion. A concentration of 20 µg/mL appears to be saturating the surface, since higher 
amounts do not further increase the signal; this concentration was therefore used 
in subsequent experiments. Using this concentration for peptide immobilisation, the 
binding rate (dR/dt) for the same serum dilution series was determined for 3 differ-
ent peptides and normalised for the serum dilution (Figure 4.3b). With the expected 
linear relationship between binding rate and concentration, this should yield the 
same values for each dilution factor. This is the case for the 100-fold and 300-fold 
dilutions. Further diluted samples gave much lower signals, which decreased the 
reliability of the data (Figure 4.3a).
A third parameter to consider is the diffusion rate (L
m
) of the analyte. A classic test to 
check for mass transport limited conditions is to change the diffusion rate between 
the surface layer and the bulk of the solution by changing the flow rate in the flow 
cell. If the interaction is mass transport limited, an increase in flow rate will result 
in an increased binding rate. An analysis was performed at two different flow rates: 
10 µl/s and 50 µl/s (Figure 4.4). The binding rate at the highest analyte concentra-
tions was markedly increased upon increasing the flow rate. At the same time, the 
observed binding rate at 10 µl/s, corrected for the dilution factor, is relatively con-
sistent across all three dilutions. Taken together, these data indicate that the inter-
actions are limited by mass transport at the lower flow rate. 
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Figure 4.4: Influence of flow rate on binding rate of ACPA to peptides 10 and 11. Analyses were per-
formed with three serum dilutions as indicated in triplicate spots (depicted are mean with standard 
deviation). The binding rate was determined in the first 60 s after injection and normalized to the 
serum dilution.
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In Figure 4.4 it can also be seen that the optimal dilutions might both depend on the 
serum sample and the peptide. For peptide 11 the most dilute serum sample yields 
barely detectable binding signals (data not shown), which are inflated due to the 
normalisation, resulting in a slightly aberrant binding rate. On the other hand, the 
binding rate for peptide 10 was slightly lower at the highest concentration, probably 
because at this dilution the peptide binding rate is too slow to cope with the higher 
mass transport, which makes it no longer limiting. These differences are likely 
caused by differences in affinities and/or concentrations of the antibodies in the 
serum directed to the various peptide epitopes. These results emphasize the need for 
multiple dilutions over a rather wide range, to achieve the required dynamic range. 
Due to this effect, for accurate measurements only the two subsequent dilutions that 
result in a similar value should be considered (i.e. either the two lowest or the two 
highest dilutions). These should also have the highest normalised binding rate, since 
both of the above phenomena lead to a reduction of the binding rate.
Reproducibility
After establishing the required conditions for the screening assay, the reliability of 
the assay was tested by several reproducibility tests with twenty peptides selected 
from the 43 peptides described above (Figure 4.1). First, an ACPA positive serum was 
analysed in duplicate on the same iSPR chip and subsequently an identical analysis 
was performed on a separate iSPR chip. The results of the measurements on the 
same chip showed a strong correlation (r2=0.98) (Figure 4.5a). However, a compar-
ison of the measurements on two distinct chips revealed more pronounced varia-
tion (r2=0.86) (Figure 4.5b), although the correlation was still better than what was 
observed for the equilibrium response method, which yielded r2 values between 0.77 
and 0.83. Next, the stability of the immobilised peptides during multiple cycles of 
measurement and surface regeneration was determined. Typically, the immobilized 
streptavidin and peptides on the surface of the iSPR chip can withstand a limited 
number of such regeneration cycles, before denaturation or degradation starts to 
seriously impact the results by reducing the quantity of functional antibody targets 
on the surface below the level needed for mass-transport limited conditions. Due to 
the 96-wells format of the autosampler in the IBIS MX96 iSPR and the use of three 
dilutions per sample, we were limited to 32 samples that could be measured in one 
session before the instrument had to be reset and a new session could be started 
with the same chip. Two of such sessions of 32 samples were run with a regularly 
repeated ACPA-positive control serum (Figure 4.5c and d). Between the first and 
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thirty second measurement the data for the control serum were almost identical 
(r2= 0.97), but during the second session a slight reduction was observed (r2= 0.88, 
represented by the 54th cycle in Figure 4.5c). This shows that the results during the 
first 32 cycles are very reproducible. Starting a new session on the same chip leads 
to more variation in the results, especially with highly reactive peptides, but remains 
comparable to chip-to-chip variation. Eventually, after about 60 cycles in total, the 
results started to deviate more dramatically and the chip appeared to be ‘worn out’, 
as can be seen from the sharp drop in the correlation with the first measurement 
(Figure 4.5d).
Figure 4.5: Reproducibility of binding rate analysis on a single iSPR chip, between iSPR chips and over 
multiple measurement cycles. Measurements with ACPA-positive RA serum are compared for a) two 
subsequent measurements immediately following each other, b) two independent measurements, per-
formed on two separate iSPR chips and c) between the 1st (x-axis), 32nd and 54th (y-axis) measure-
ment on a single chip d) Correlation between binding rate measurements of a single ACPA-positive 
RA serum performed at various positions during measurement and regeneration cycles during two 
consecutive sessions of 32 cycles. The correlation coefficient (r2) in relation to the first measurements 
is depicted in the graph. The grey line in panels a-c indicates the optimal correlation.
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4.4. Conclusions
In this study we optimized profiling the fine-specificity of ACPA in sera of RA patients 
by microarray-iSPR. A wider set of ACPA fine-specificities can be detected by replac-
ing poorly or non-reactive peptides in the citrullinated peptide array by other citrul-
linated peptides that are more frequently reactive with RA sera. The new peptides 
that were introduced are based on histone H2A and H4, vinculin, clusterin and 
myelin basic protein. In addition, the reproducibility was improved by developing 
an analysis method based on real-time binding rates instead of binding equilibria. As 
a result, the variance due to peptide immobilisation was reduced and this approach 
has made it possible to determine a proxy for antibody titers that is independent 
of affinities. Besides more accurate data, the short association periods needed to 
determine binding rates enable the execution of more analyses in the same period 
of time, which is important for profiling large sample sets. Currently, we are apply-
ing this new method to profiling ACPA in sera of patients with four distinct ethnic 
backgrounds to see whether there is an immunochemical correlation with the noted 
difference in RA prevalence.
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I am among those who think that science has great beauty. A scien-
tist in his laboratory is not only a technician: he is also a child placed 
before natural phenomena which impress him like a fairy tale.
Marie Curie, chemist and physicist 
Madame Curie: A Biography, 1937
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A common feature for small heat-shock proteins is their formation of dynamic, large oligomeric complexes. For one of the most studied members of this fam-
ily, αB-crystallin, the dynamics of subunits entering and leaving these complexes 
appears related to its chaperone-like activity. This dynamic behaviour appears to 
differ between higher and lower pH values, which might reflect a mechanism trig-
gered by acidification. To further characterize αB-crystallin complex dynamics, we 
have developed a model based on previous studies to the changing distribution of the 
number of subunits in a complex. This model describes the binding behaviour of these 
complexes to single subunits immobilized on the surface of a surface plasmon reso-
nance chip. Although our experimental results showed relatively low specific binding 
levels, which impedes quantitative analyses, they indicated pH-sensitive dynamics 
in agreement with the proposed binding model and the previously reported binding 
behaviour.
5.1. Introduction
Small heat-shock proteins (sHSPs) are a family of proteins that exhibit chaperone-like 
activity. By binding other proteins in non-native conformations, they prevent aggre-
gation and maintain protein homeostasis. This creates a reservoir of non-native pro-
teins that are substrates for subsequent refolding by ATP-dependent chaperones.1,2 
sHSPs are widespread and several members of this family display basal activity under 
normal physiological conditions, which is enhanced upon cellular stresses that pose 
a risk to protein folding like heat, toxicants or hypoxia.3 This enhancement is regu-
lated through various means, like temperature or pH dependent binding affinities, 
or phosphorylation of specific residues to alter protein structure.4 Although sHSPs 
are diverse, they share a set of common structural features, including a conserved 
α-crystallin domain, a relatively small molecular mass typically between 12-43 kDa 
and the propensity to form large oligomers. This organization into large oligomers 
may be one of their most interesting features, providing a highly dynamic quater-
nary structure containing a widely varying number of subunits.
The most extensively studied member of this family is α-crystallin, a major constit-
uent of the mammalian eye lens. In the human lens, protein concentrations up to 
450 mg/mL are required to achieve the right refractive index. To maintain protein 
homeostasis in such dense environment with little to no protein turnover, about 35% 
of all proteins are α-crystallins, spread in a 3 to 1 ratio between αA-crystallin (HspB4) 
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and αB-crystallin (HspB5).5,6 While αA-crystallin is nearly absent from non-lenticular 
tissues, the highly similar αB-crystallin is found in a variety of different tissues, espe-
cially skeletal and cardiac muscle. Here, it is present in hetero-oligomers with Hsp27 
(HspB1), HspB6 and HspB8, all of which are sHSPs with chaperone activity, suggesting 
that these mixed complexes may have chaperone function too.7
αB-crystallin forms dimers that assemble into polydisperse, oligomeric globular 
structures. In these structures, a single subunit has two types of interactions with 
other subunits: an inter-subunit interaction mediating oligomerisation and the bind-
ing between monomers to form dimers (for clarity we call the former an ‘edge’ inter-
action).8 The subunits in these oligomeric complexes are readily exchanged, a process 
which has been associated with their chaperone function. To understand this pro-
tective function of αB-crystallin, insight in oligomer dynamics is required. However, 
the polydispersity and highly dynamic nature of these complexes have complicated 
the interpretation of experimental results aimed at a better understanding of this 
process. Recently, Baldwin and coworkers were able to study the oligomeric dis-
tribution and subunit exchange kinetics by means of nanoelectrospray mass spec-
trometry.9,10 Their results showed that the αB-crystallin oligomer dynamics could be 
described solely by the two distinct interactions between subunits, the inter-dimer 
and edge interaction, both independent of the size of the oligomer. Interestingly, 
while the observed average oligomer-size remained the same, the subunit exchange 
dynamics and distribution around the average changed dramatically with a change 
in pH within a physiologically relevant range. This indicated a balance between the 
two interactions, with the intra-dimer interaction being strong at high pH, lead-
ing to predominantly even-numbered oligomers, while at low pH the intra-dimer 
interactions weakened and inter-dimer, or ‘edge-’, interactions became stronger, 
giving an equal distribution of even- and uneven-numbered oligomers (Figure 5.1). 
It is tempting to suggest that these changes are associated with the activation of 
the chaperone due to acidification, especially in muscle cells where αB-crystallin is 
abundant and acidification can occur during exercise. This substantiates the hypoth-
esis that subunit dynamics is related to chaperone functionality.
An obvious technique to further study the kinetics of this process is surface plas-
mon resonance (SPR) spectroscopy. Instead of singular ‘snapshots,’ it allows real-
time observation of the oligomer dynamics, which is ideal for tracking of different 
kinetic rates with similar equilibrium states. This would also allow determination of 
84 | introduction chapter 5
association rates, which proved impossible by mass spectroscopy due to the unde-
tectable levels of free monomeric subunits. In addition, this technology is quite suit-
able for heterogenic mixtures, like complexes consisting of different sHSPs. While SPR 
has been used before to study α-crystallin interactions, this has only been studied as 
a single interaction and not yet been compared to the ‘edge-and-dimer’ dynamics 
model, due to the use of glutaraldehyde-11 or amine-crosslinking12,13 for immobiliza-
tion to the sensor chip, thereby likely disabling single-subunit exchange.14
To obtain more insight in αB-crystallin complex dynamics, we used the site-specific 
immobilization method based on leucine zipper peptide tags described in Chapter 
3. By tagging an αB-crystallin subunit at a defined site and using this tag for immo-
bilization, single αB-crystallin subunits were immobilized without subunit-subunit 
crosslinking. We described the binding behaviour reported by Baldwin et al.9 in a 
model suited to this situation and investigated the feasibility of using this to eluci-
date more of the complex dynamics.
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Figure 5.1: Oligomeric distributions of αB-crystallin as a function of pH. Distributions as reported by 
Baldwin et al.,9 obtained by nanoelectrospray MS at 37 °C and normalized to the total protein concen-
tration. Experimental data are shown in red, and the calculated distributions are in blue, where [Pi] 
is the concentration of an oligomer consisting of i monomers. (Reprinted from Journal of Molecular 
Biology, 413 / 2, Andrew J. Baldwin, Hadi Lioe, Carol V. Robinson, Lewis E. Kay, Justin L.P. Benesch, 
αB-Crystallin Polydispersity Is a Consequence of Unbiased Quaternary Dynamics, 297-309, Copyright 
(2011), with permission from Elsevier)
85tracking the dynamics of small heat-shock protein complexes using spr  
 
5.2. Materials & Methods
Binding simulation using model
The binding behaviour on surface-bound subunits was simulated using Mathematica 10 
(Wolfram Research, Champaign IL, USA) by parametric differential equations with the following 
parameters (see Table 5.1): the association rate (k+ as kep and kedp), edge dissociation rate (ke- 
as kem), dimer dissociation rate (ked- as kedm), oligomer concentration (oligomers containing an 
even number of subunits as concA and concB for an uneven number, which were considered to 
be in a 1:1 ratio), maximum binding capacity (Rmax) and the time-point of starting the dissoci-
ation phase (ctime).
Cloning and expression of tagged αB-crystallin
The open reading frame of human αB-crystallin was amplified by PCR and inserted into a pEN-
TR-D/TOPO (Thermo Fischer Scientific, Waltham MA, USA) vector using topoisomerase-cloning. 
This entry-plasmid was subsequently recombined with the pDNz-VinER destination-plasmid, 
described in Chapter 3, using Gateway LR Clonase II (Thermo Fischer Scientific, Waltham MA, 
USA), resulting in an expression plasmid. E. coli BL21 Rosetta(DE3)pLysS were transformed for 
expression, cultured at 37 ˚C in 2TY medium containing 100 µg/mL ampicillin and expression 
was induced when cultures achieved an optical density of 0.6 by addition of 0.5 mM isopropyl 
β-D-1-thiogalactopyranoside (MP Biomedicals, Santa Ana CA, USA). After overnight incubation, 
bacteria were spun down, resuspended in 20 mM TRIS pH 8.0, 0.5 M KCl, 6 M urea and lysed by 
freeze-thawing and sonication. The lysate was cleared by centrifugation, 20 min at 29,000 g, 
and the supernatant incubated for 2h with Ni-NTA sepharose (IBA Life Sciences, Goettingen, 
Germany). After washing, the urea was gradually diluted to allow the protein to refold by 3 sub-
sequent 1.5-fold dilutions with 20 mM TRIS pH 8.0, 0.5 M KCl (resulting in 4, 2.7, 1.8 M urea, 
respectively), followed by 3 subsequent 1.3-fold dilutions (final urea concentration 0.76 M); 
each dilution step was followed by mixing for 30 min. The beads were subsequently washed 
with 20 mM TRIS pH 8.0, 0.5 M KCl and eluted by overnight incubation with 20 mM TRIS pH 8.0, 
0.5 M KCl, 0.5 M imidazole. Eluted proteins were analysed by SDS-PAGE and dialyzed to PBS 
using a 3k MWCO membrane.
Expression of untagged αB-crystallin
Recombinant human αB-crystallin was expressed from a pET16b vector by transformation of 
E. coli BL21 Rosetta(DE3)pLysS and culturing in LB broth containing 100 µg/ml ampicillin at 
37 °C until an optical density of 0.35 was reached. Expression was induced by the addition of 
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800 µM isopropyl β-D-1-thiogalactopyranoside, after which bacteria were cultured for 3 hours 
at 37 °C. Bacteria were pelleted and resuspended in 15 mL TEG50 (25 mM Tris-HCl, pH 8.0, 2 mM 
EDTA, 50 mM glucose), lysed by sonication and cleared by centrifugation. The supernatant was 
fractionated on a DEAE fast flow column using a linear 0 – 1 M NaCl gradient in 25 mM Tris-HCl, 
2 mM EDTA, pH 8.0. Purified αB-crystallin containing fractions were pooled and dialysed against 
PBS, aliquoted, frozen in liquid N2 and stored at -20 °C. Depending on the required buffer and 
pH-value during the analysis, aliquots were dialysed against the target analysis buffer with the 
desired pH (either PBS adjusted to pH 6.8 or pH 8.0, 25 mM MES with 25 mM HEPES pH 8.0 or 25 
mM sodium phosphate with 25 mM citrate pH 5.0, all containing 0.075% Tween-80).
SPR analysis
Leucine-zipper tagged and untagged αB-crystallin were mixed in a 1:30 molar ratio and incu-
bated for at least 1h. A chip surface was functionalized with the RE leucine zipper peptide, 
complementary to the tagged αB-crystallin (mercaptopropionic acid-LHDLHDLEIRAAFLRQRN-
TALRTEVAELEQEVQRLENEVSQYETRYGPLGGGGK), mixed in 1:20 molar ratio with an anti-foul-
ing peptide (mercaptopropionic acid-LHDLHD) as described in Chapter 3. Subsequently, the 
αB-crystallin mixture was incubated for 1 h with the surface using a continuous flow micro-
spotter (Wasatch Microfluidics, Salt Lake City UT, USA). Following immobilization, unbound 
complexes and untagged subunits were removed by thoroughly washing the chip surface for 
at least 1 h at 37 ˚C with 100 µl/s PBS containing 0.075% Tween-80 in the flow cell of an IBIS 
MX96 SPR system (IBIS Technologies, Enschede, The Netherlands). Subsequently, the chip was 
equilibrated with the target analysis buffer and sensorgrams were recorded during 1 min base-
line incubation, 60 min association with 1 mg/mL αB-crystallin in PBS with 0.075% Tween-80 
under continuous back-and-forth flow, and at least 30 min dissociation with 100 µl/s flowrate. 
In some experiments the surface was regenerated by 1 min incubation with glycine-HCl, pH 
2.0. Sensorgrams were calibrated and specific binding signals were obtained by subtraction of 
non-specific binding signals on areas of the surface without immobilized αB-crystallin using 
SprintX software.
Fitting association rates
Association rates were fitted using Mathematica 10 by calculating the estimated response 
for measured time-points with the model used for simulation. Subsequently, a least-squares 
estimate was generated by minimizing the sum of squares between measured and calculated 
responses for association rates between 0 and 1000 M-1 s-1 and a maximum response between 
100 and 1000 RU (Table 5.1).
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5.3. Results and Discussion
Binding model
Quantification of binding kinetics by SPR relies on the ability to properly model 
the binding behaviour and fit this model with experimental data. To analyse the 
αB-crystallin dynamics the reported binding behaviour9 thus needed to be adapted 
to the experimental situation of an SPR analysis. Where Baldwin and coworkers ana-
lysed exchange rates of subunits between oligomers, SPR relies on association to and 
dissociation from a surface-immobilized binding partner, in this case an αB-crystallin 
subunit. This results in three measurable surface-interactions, depicted in Figure 5.2. 
However, the concentration of monomeric subunits is extremely low relative to the 
oligomers. Additionally, the SPR response is mass sensitive which means that asso-
ciation of a large oligomer results in a much higher signal than for the association 
of a single subunit. Therefore, the SPR signal obtained from interactions with single 
subunits was considered to be negligible (like the rightmost interaction in Figure 
A B
C
D E
ke- kde-
k+k+
kde-
Figure 5.2: Schematic representation of the αB-crystallin interactions on the SPR sensor surface. 
The most important oligomeric states of αB-crystallin during SPR analysis are indicated: A) even 
numbered oligomers in solution B) uneven numbered oligomers in solution C) free surface-bound 
subunit D) uneven numbered oligomer on the surface and E) even numbered oligomer on the surface. 
Interactions involving free monomers were considered negligible. The rate constants relevant for each 
interaction are indicated as well: ke- for dissociation of a single edge interaction in uneven numbered 
oligomers, kde- for the dissociation of a combined edge and dimer interaction in even numbered oli-
gomers and k+ for association.
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5.2). This considerably reduced the number of relevant interactions on the surface, 
leaving five states of interest: the even (A) and uneven (B) oligomers in the solution, 
which are roughly constant due to their excess, the single subunits immobilized on 
the surface (C), and uneven (D) and even (E) oligomers bound on the surface (Figure 
5.2). The interactions between these: association of even oligomers to the surface 
becoming a bound uneven oligomer, association of uneven oligomers becoming 
bound even oligomers, the corresponding dissociations and finally, loss of one sub-
units from a surface-bound oligomer (which contains on average 28 subunits, but 
results in 1/28th response due to the smaller mass), could then be described by the 
following differential equations:
With k-
e
 the dissociation rate for edge interactions, k-
de
 the dissociation rate with 
both edge and dimer interactions and k+ the association rate. The SPR response then 
is the sum of the responses from the surface bound oligomers, D and E.
The binding described by this model was compared with the previously reported 
behaviour by running a simulation using the binding rates reported by Baldwin and 
coworkers. The result is depicted in Figure 5.3 and indicates a similar behaviour: 
subunit exchange is much more rapid at low pH, resulting in the much faster asso-
ciation and dissociation at pH 5 than at pH 9 seen in Figure 5.3c. Typical for the 
expected behaviour is that while the curve shape is widely different between the 
two pHs, equilibrium response levels are not far apart, indicating different binding 
kinetics with similar overall affinity. In addition, at pH 5 the response from uneven 
numbered oligomers (Figure 5.3a) is roughly equal to the response from even num-
bered oligomers (Figure 5.3b). In contrast, at pH 9 the uneven numbered oligomers 
are vastly outnumbered by the even numbered oligomers, a result of the predom-
inant role of the dimer interaction (Figure 5.3b and Figure 5.3c are nearly equal for 
pH 9). This correlates with the results obtained by mass spectrometry analysis of the 
oligomers, which shows a Poisson-distribution at pH 5 and mostly the presence of 
even numbered oligomers at pH 9.
= − ∙ ( ) ∙ ( ) − ∙ ( ) ∙ ( ) + ∙ ( ) + ∙ ( )  
= ∙ ( ) ∙ ( ) − ∙ ( ) +
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SPR analysis
With a model that describes the αB-crystallin binding behaviour in place, an SPR 
experiment was set up. To obtain well-defined immobilization of an αB-crystallin 
subunit, a leucine zipper-tagged subunit was used. Because the C-terminus of sub-
units is known to be involved in edge- (inter-dimer) interactions,15 whereas the 
N-terminal domain is involved in substrate binding,16 the leucine zipper was fused to 
the N-terminus.  The pDNz-VinER plasmid described in Chapter 3 was used as it read-
ily includes an N-terminal zipper tag for immobilization, as well as an oligo-histidine 
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Figure 5.3: Simulation of SPR curves with the described model at low and high pH. a) The response 
from uneven numbered oligomers binding to the surface (D in Figure 5.2). b) The response from even 
numbered oligomers binding to the surface (E in Figure 5.2). c) The expected total SPR response, 
the sum of (a) and (b), with enlargement of the area between 0 and 100 s. The simulation was based 
on previously reported9 rate constants at 37 ˚C: k+ = 106 M-1 s-1, ke- = 0.1 s
-1, kde- = 0.03 s
-1 at pH 5, 
k+ = 0.1·106 M-1 s-1, ke- = 3·10
-3 s-1, kde- = 50·10
-6 s-1 at pH 9, with 0.1 µM of αB-crystallin oligomer in 
solution (which is about 50 µg/mL) and 2000 RU maximum binding capacity.
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tag for purification. SDS-PAGE analysis revealed co-elution of untagged subunits 
when incubated on a Ni-NTA column loaded with tagged subunits, indicating both 
were integrated in αB-crystallin complexes, with the band intensity suggesting a 
ratio of 2 to 3 tagged subunits per oligomer (Figure 5.4).
An SPR chip surface functionalized with the complementary leucine zipper peptide 
was incubated with the tagged αB-crystallin complexes and by extensive washing 
the non-tagged subunits were allowed to dissociate from the complex and surface 
and were removed (Figure 5.5). This resulted in a surface to which monomeric sub-
units were attached via the leucine zipper. To study the interaction of the immobi-
lized monomeric αB-crystallin subunits with αB-crystallin complexes, the surface 
was subsequently incubated with purified non-tagged complexes. 
A relatively high non-specific binding to regions of the chip without immobilized 
αB-crystallin was observed (Figure 5.6). This was probably caused by the unpaired 
somewhat hydrophobic and rather unstructured free leucine zipper peptides on 
the surface which mimics a typical substrate for αB-crystallin. We explored various 
94
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Figure 5.4: SDS-PAGE analysis of tagged αB-crystallin subunits. On the left purified tagged subunits, 
on the right tagged subunits that eluted from a Ni-NTA column after washing with untagged subunits. 
In this situation there is a clear co-elution of untagged subunits that have been bound by the tagged 
subunits on the column.
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Figure 5.5: Dissociation of immobilized αB-crystallin complexes. Sensorgram of αB-crystallin subunit 
dissociation during washing at 37 ˚C with PBS after immobilization.
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buffering compounds and salt concentrations in the pH range of interest (pH 6-9) 
to reduce these interactions. Based upon the results PBS was used as condition for 
binding experiments. 
Analyses were performed in PBS at pH 6.8 and pH 8.0 (Figure 5.7). These conditions 
were chosen based on buffering range of phosphate (pH 6.0 – pH 8.0), the expected 
pH-dependent behaviour between pH 5.0 and 9.0 and to avoid potential precipi-
tation effects of αB-crystallin at low pH (some precipitation was observed during 
dialysis to low pH and therefore analysis was performed above its theoretical pI 
of 6.7). Incubation of immobilized αB-crystallin with complexes indeed resulted 
in increased SPR responses. However, only a small amount of the αB-crystallin in 
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Figure 5.6: Non-specific binding of αB-crystallin to the chip surface. Sensorgrams of non-specific bind-
ing to areas of the SPR chip lacking immobilized αB-crystallin subunits, in 5 separate experiments 
with 1 mg/mL αB-crystallin in PBS, phosphate-citrate or MES-HEPES buffers, all containing 0.075% 
Tween-80.
1000 2000 3000 4000 5000 6000
50
100
150
pH 8.0
pH 6.8
Time [s]
R
es
po
ns
e 
[R
U
]
Figure 5.7: Binding of αB-crystallin complexes to immobilized subunits. Sensorgram of 1 mg/mL 
αB-crystallin binding to immobilized subunits at pH 6.8 and pH 8.0 at 25 ˚C, overlaid in red with a fit 
of the association phase using the binding model. Dissociation constants were set at ke- = 2·10
-3 s-1, 
kde- = 100·10
-6 s-1 at pH 6.8, ke- = 100·10
-6 s-1, kde- = 5·10
-6 s-1 at pH 8.0. Least-squares fit of k+ = 526 
M-1 s-1 at pH 6.8 and k+ = 163 M-1 s-1 at pH 8.0.
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solution appeared to participate in binding. The binding response during association 
was far lower than what would have been expected based on the SPR values prior to 
dissociation of the non-immobilized subunits in Figure 5.5. In fact, only when rela-
tively high concentrations (0.5-1 mg/mL) of αB-crystallin were used, specific binding 
was measured.
Nevertheless, the association phase could be well fitted with the model when using 
dissociation rates reported by Baldwin et al.9 The sensorgrams as well as the fit-
ted curves, depicted in Figure 5.8, showed the expected pH influence on binding 
behaviour. The low association rates reflect the hypothesis that only very few of the 
oligomers in solution are actively binding, skewing the k+ estimate that depends on 
an accurate concentration.
The dissociation phase on the other hand, diverged from the model, yielding a 
two-phasic dissociation for pH 8.0 and generally a slower rate. A potential cause 
could be that the oligomers that were actively binding are only those of smaller 
sizes. This subset would be small, relatively heterogeneous and show a lower dis-
sociation rate as smaller oligomers result in less signal decrease when dissociating 
and have less subunits that can dissociate from the complex individually. As a result, 
our model, which assumed average complex sizes, does not accurately reflect the 
situation on the SPR chip during the dissociation phase.
5.4. Conclusions and Outlook
Overall, our current SPR methodology confirmed the pH-dependent binding 
behaviour described by the binding model, but could not be used to reliably estimate 
binding constants due to high non-specific binding to the surface of the SPR chip and 
very inefficient binding of αB-crystallin from solution to the subunits immobilized on 
the surface. 
10 ng/mL   50 ng/mL  100 ng/mL
Figure 5.8: αB-crystallin oligomers bound to the SPR chip. The chip surface containing immobilized 
leucine zipper peptides was incubated with 10, 50 or 100 ng/mL leucine zipper-tagged αB crystallin 
oligomers. The intensity of the spots corresponds to the mass on the surface measured by a shift in 
SPR angle.
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A better defined result will likely be achieved by change of immobilization method. In 
this case, the unstructured, somewhat hydrophobic leucine zipper peptides bound to 
the chip surface might have acted as αB-substrate. Furthermore, the results seemed 
to indicate an effect inhibiting larger complexes from binding. For example, through 
the rigid structure of the leucine zipper once paired, or instability of a lone subunit 
on the surface. Although the specific immobilization provided by the leucine zipper 
is clearly required, alternatives that are less prone to interact with αB-crystallin are 
Parametric dierential equations used in simulating binding behaviour : 
 
Fitting experimental with model data by min imizing sum of squares:  
 
 
Table 5.1: Mathematica model for simulation of binding behaviour and fit with experimental data.
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more recommended. Similar to implement are site-specific biotinylation or use of 
the oligohistidine purification tag. With such a different immobilization method care 
should be taken to provide sufficient spacing and flexibility between surface and 
immobilized subunit to allow a large complex to bind. The continuously improving 
structural information of this protein can also be useful to optimise the location of 
a tag.
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Combining multiple functionalities in supramolecular complexes is key to many biological systems. De-novo design of such protein complexes might create new 
functionalities within a cellular environment. Leucine zippers are promising candi-
dates to act as modular linkers between proteins within a complex. We demonstrated 
such use of leucine zippers in both extracellular and intracellular environments. 
Extracellularly, we used leucine zippers to trigger cellular import of a protein cargo 
by activating a cell-penetrating peptide. This type of inducible import can be highly 
useful for targeted drug delivery applications. Intracellularly, we showed the feasibil-
ity of using engineered leucine zippers to create self-assembled complexes by mon-
itoring the leucine zipper-mediated dimerization of fluorescent proteins by means 
of Förster Resonance Energy Transfer. Such controlled complex formation can be a 
useful tool for future manipulation of intracellular processes.
6.1. Introduction
Assembly of a limited set of different components into a higher-order structure to 
provide new functionality is one of the hallmarks of biological systems. Whether it 
are four nucleobases assembled in the famous DNA-helix, which in turn assembles 
into even larger building blocks all the way to a chromosome, storing large amounts 
of information, or the 20 amino acids that can be combined and folded into virtually 
limitless three-dimensional structures with a variety of chemical moieties, the com-
bination of multiple components provides new functionalities. 
Key to combining the functionality of different molecules are supramolecular inter-
actions. These interactions are responsible for the assembly, maintenance and dis-
assembly of components in a supramolecular structure. Modern nanotechnologies 
try to mimic or integrate in such behaviour, and control of these interactions is 
therefore of considerable interest. 
The biological context of a cell, with a large amount of potentially competing mol-
ecules, puts high requirements on the specificity and affinity of supramolecular 
interactions. Due to the complexities involved, de-novo design of multi-component 
protein systems remains challenging.1–6 Promising are systems that make use of mod-
ular linkers, which require only a limited set of similar peptide or protein structures 
that link widely different functional protein domains together. For example through 
highly modular fusion protein systems like BglBricks,7 which allow combination of 
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functional modules, such as ‘interaction modules’, by combining different coding 
regions. Or by fusion of engineered linkers like tetratricopeptide repeat affinity pro-
teins (TRAP) that recognize non-naturally occurring peptide sequences, so they can 
function as orthogonal linkers of protein structures.8
Another class of linkers of protein structures are leucine zippers. Originally found 
in transcription factors of the bZIP family, these leucine zippers consist of two pep-
tide chains that form a coiled coil structure upon binding.9 This interaction is medi-
ated by a hydrophobic leucine residue, repeating every seven amino acids and thus 
appearing on one side of the helical structure. In between, oppositely charged res-
idues like glutamic acid and arginine can be used to tune the interaction and ‘code’ 
the leucine zippers for orthogonal dimerization, similar to DNA base-pairing.10 In 
this chapter we show two different applications of these leucine zippers as linkers in 
protein complexes: one extracellular and one intracellular.
A first interesting application for multi-component systems is drug delivery, espe-
cially intracellular drug delivery, as shown previously using dynamic assembly of 
cell penetrating polymers.11 Intracellular drug delivery often needs targeting to a 
specific tissue and thus an on and off state. The cellular membrane represents an 
impermeable barrier to many pharmaceutically relevant compounds, which are 
therefore by default inactive.12 Cell-penetrating peptides (CPPs) possess the ability 
to quickly enter living cells, and are therefore regarded as promising candidates for 
the delivery of such bioactive cargoes into cells.13 One of the main limitations of CPPs 
remains however their lack of specificity: regular CPPs enter almost any cell type at 
Figure 6.1: Schematic representation of the coiled-coil mediated CPP activation strategy. X repre-
sents either an alanine or cysteine residue.
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any given moment, and thus are always ‘on’ and deliver drugs to both healthy and 
diseased cells.14–16 Recently, a split CPP consisting of two short, inert oligo-arginines, 
both functionalized with a cysteine residue was reported.17,18 Upon disulphide forma-
tion, an active CPP containing eight or nine arginine residues was obtained, giving 
temporal control over the uptake. Here, we have studied the ability of the highly 
specific coiled coil interaction of the leucine zipper to achieve reconstitution of the 
split CPP and thereby control the triggered cell uptake of a fluorescent cargo protein 
(Figure 6.1). 
Because leucine zippers consist entirely of natural amino-acids, it is possible to not 
just create in-vitro or extracellular complexes like the coiled-coil activated CPPs, but 
to build intra-cellular complexes inside the cell, through expression by the target 
cell. Such ability is valuable to report and manipulate the highly modular cellular sig-
nalling systems.19 There have been few applications of these leucine zipper peptides 
in an intracellular environment. One interesting example developed by Zhang et al., 
who visualized specific cellular activity by combinatorial cell marking using a split 
GFP fused to coiled-coil peptides. This allowed labelling of a specific cell type only 
when a certain (promotor-controlled) activity was present, a selectivity that would 
not be possible with a single reporter.20 
sfGFP
leucine zipper
cleavable (P2A) peptide
mStrawberry
zipper-paired unpaired linker-paired
linker peptide
Figure 6.2: Schematic representation of the three fusion proteins. Depicted are the expression cas-
settes and expected protein structures. Indicated is the expected fluorescence emission (green: no 
FRET, red: FRET) upon excitation with 485 nm light (blue).
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We have tested the feasibility of using two strongly interacting artificial leucine zip-
pers to create intracellular protein complexes. By co-expressing these leucine zip-
pers fused to two fluorescent proteins, superfolder-GFP (sfGFP)21 and mStrawberry22, 
the expression could be visualized and the intracellular dimerization of these leucine 
zippers determined by comparing Förster Resonance Energy Transfer (FRET) of the 
zipper-paired with unpaired (negative control) and linker-paired fluorescent pro-
teins (positive control) (Figure 6.2).
6.2. Materials & Methods
Coiled-coil activated cell-penetrating peptides
The coiled-coil activated cell-penetrating peptides consisted of two parts: a synthetic leucine 
zipper-peptide with four arginines (Acetyl-RRRR-C/A-GGGG-LEIEAAFLERENTALETRVAELRQRVQ
RLRNRVSQYRTRYGPLGGGK) and an expressed fluorescent cargo protein, fused to the comple-
mentary leucine zipper-peptide and another four arginines (HHHHHH-C/A-RRRR-LEIRAAFLRQR
NTALRTEVAELEQEVQRLENEVSQYETRYGPL-sfGFP/mStrawberry).
Peptide synthesis was performed on polystyrene Rink amide resins using a Labortec640 peptide 
synthesizer (Labortec, Bubendorf, Switzerland), employing a standard Fmoc solid-phase pep-
tide synthesis (SPPS) protocol. In brief, the resin was swollen in DMF for 30 minutes prior to use. 
The Fmoc protecting groups were removed by mixing the resin with piperidine in DMF (20%, 
v/v; 3 times for 6 minutes). The desired sequence of amino acids was coupled to the resin using 
Fmoc-L-amino acids (3.0 equiv), diisopropylcarbodiimide (DIPCDI, 3.3 equiv) and N-hydroxy 
benzotriazole (HOBt, 3.6 equiv).  Peptide couplings were monitored using the Kaiser test.23 After 
the final Fmoc removal, the N-terminus was acetylated by agitation in a mixture of pyridine (1 
mL) and acetic anhydride (1 mL) in DMF for 10 minutes. Afterwards, the resin was washed thor-
oughly with DMF, DCM, i-PrOH, DCM and Et2O and dried in vacuo. The peptides were cleaved 
from the resin by suspension in a mixture of trifluoroacetic acid/water/triisopropyl-silane/thio-
anisole (90:5:2.5:2.5 v/v/v/v) for 6 h. The free peptides were precipitated in Et2O, redissolved in 
water and lyophilized yielding the crude peptides. The crude peptides were purified by reversed 
phase HPLC and subsequently lyophilized yielding a yellow powder.
Peptide purity was analyzed using analytical reversed phase HPLC on a Shimadzu LC-20A 
Prominence system (Shimadzu, ‘s-Hertogenbosch, The Netherlands), equipped with a 
ReproSil column (Screening Devices, Amersfoort, The Netherlands). Semi-preparative RP-HPLC 
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purification of peptides was performed using a c18 column (250 x 10 mm, particle size 5 µm, 4 
mL/min flow or 150 x 20 mm, particle size 10 µm, 8 mL/min flow) and a MeCN/water gradient 
containing 0.1% trifluoroacetic acid (5-100%, 1-50 min). The purity of the fractions was assessed 
by analytical RP-HPLC using a C18 column (150 x 3 mm, particle size 3 µm, peptide retention 
time was 17.1 mins). Peptides were eluted in an aqueous acetonitrile gradient containing 0.1% 
TFA (v/v) (5 - 100%, 1 - 40 min., flow 0.4 mL/min). Peptide mass characterization was performed 
by electrospray ionization time-of-flight (ESI-TOF) on a JEOL AccuTOF. Deconvoluted mass spec-
tra were obtained using MagTran 1.03b2 ([M+H]+ 6875.2 - calculated 6875.4).
The constructs for the expression of the cargo protein (Figure 6.10) were made using two par-
tially complementary oligonucleotides coding for the leucine zipper, flanked by restriction sites 
(Biolegio, Nijmegen, The Netherlands – Table 6.1). These were elongated by overlap-extension 
PCR. The product with 3’ A-overhang was inserted into a pCR4-TOPO vector (Thermo Fisher 
Scientific, Waltham MA, U.S.A.). An XhoI restriction site was introduced upstream of the recom-
bination site in a pDEST17 destination vector (Thermo Fisher Scientific, Waltham MA, U.S.A.) by 
site-directed mutagenesis. Subsequently the sequence for the leucine zipper was cut from the 
pCR4 plasmid using XhoI (New England Biolabs, Ipswitch MA, U.S.A.) and ligated into the mod-
ified pDEST17 vector using T4 ligase (New England Biolabs, Ipswitch MA, U.S.A.) and used to 
transform Escherichia coli ccdB Survival 2 T1R (Thermo Fisher Scientific, Waltham MA, U.S.A.). 
The CRRRR and ARRRR sequences were introduced by site-directed mutagenesis with partially 
overlapping primers.24 Superfolder-GFP21 and mStrawberry22 sequences were PCR amplified and 
inserted into a pENTR/SD/D-TOPO entry vector (Thermo Fisher Scientific, Waltham MA, U.S.A.). 
These plasmids were then recombined with the pDEST17 plasmid containing CRRRR or ARRRR 
sequences in a Gateway LR reaction using LR clonase II (Thermo Fisher Scientific, Waltham MA, 
U.S.A.) (Figure 6.10).25 Resulting expression constructs were confirmed by sequencing.
Escherichia coli BL21 AI (Thermo Fisher Scientific, Waltham MA, U.S.A.) was transformed with 
these expression constructs. Single-colonies were used for expression to inoculate 1.5 L of 2TY 
containing 100 µg/mL ampicillin, which was grown at 37 °C, 200 rpm until an optical density 
of 0.6 was reached. At that time, protein expression was induced with 0.1 %(w/v) L-arabinose 
(Sigma-Aldrich) and 0.5 mM isopropyl β-D-1-thiogalactopyranoside (MP Biomedicals, Santa 
Ana CA, U.S.A.) followed by an overnight incubation at 25 °C. Cells were harvested by centrif-
ugation, resuspended in phosphate buffered saline and lysed by sonication. Soluble fractions 
were obtained by 20 min centrifugation at 29,000 g and incubated with Ni-NTA sepharose (IBA, 
Goettingen, Germany) to bind the poly-histidine tag present in the pDEST17 vector. After incu-
bation the suspension was cast in a column and washed with wash buffer (20 mM Tris-HCl, pH 
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8.0, 500 mM KCl, 20 mM imidazole, 10 % glycerol), wash buffer with 1 M KCl and wash buffer with 
50 mM imidazole. Bound proteins were eluted (20 mM Tris-HCl, pH 8.0, 100 mM KCl, 500 mM imi-
dazole, 10 % glycerol) and analyzed by SDS-PAGE (Figure 6.13).  The buffer was then exchanged 
by 50 mM Tris-HCl, pH 8.0 and samples were concentrated using 10 kDa MWCO centrifugation 
filters (Merck Millipore, Darmstadt, Germany). Protein concentrations were determined by spec-
trophotometry using the extinction coefficient21 of 8.33 x 104 M-1 cm-1 for sfGFP at 485 nm using 
a Nanodrop 1000 (Thermo Fisher Scientific, Waltham MA, U.S.A.).
Cell uptake
HeLa-CCL2 cells were maintained in sterile conditions in Dulbecco’s modified Eagle medium 
(DMEM) or Roswell Park Memorial Institute medium (RPMI) (Gibco, Invitrogen, Eugene, U.S.A.) 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS; PAN Biotech). All cells were 
incubated at 37 ˚C in a humidified atmosphere of 5 % CO2. Cells were passaged every 2 to 3 days. 
For cell uptake experiments the cells were seeded in chambered coverslips (Nunc, Wiesbaden, 
Germany) that were coated using a 0.1% gelatin solution, at a density of 40,000 cells (one day) 
or 20,000 cells per well (two days prior) to the experiment. Cells were incubated with the protein 
or protein/peptide complex (5 µM) for 90 min at 37 ˚C. Cells were washed twice after incuba-
tion with DMEM + 10 % FBS and living cells were analyzed immediately by confocal micros-
copy using a TCS SP2 confocal microscope (Leica Microsystems, Mannheim, Germany) equipped 
with an HCX PL APO 40 x N.A. 1.2 water immersion lens. sfGFP was excited by an argon laser at 
488 nm and emission was collected between 500 and 550 nm. 
FRET constructs
Plasmids encoding for the FRET constructs (Figure 6.11 & 6.12) were generated by combination 
of five parts: two fluorescent proteins, two leucine zippers and a linker. Next to the previously 
mentioned VinA/B leucine zipper sequences another pair was used. These WoolA/B leucine zip-
pers were designed to be similarly strong heterodimers, but with shorter peptides.26 Sequences 
coding for sfGFP, mStrawberry and leucine zippers were amplified by PCR, using primers 
that created overlap with their neighbouring sequences (see Table 6.1, Biolegio, Nijmegen, 
The Netherlands). The sfGFP-zipper and mStrawberry zipper sequences were separated by a 
sequence encoding the P2A peptide sequence, which was introduced from complementary 
oligonucleotides (Biolegio, Nijmegen, The Netherlands) and provides co-translational cleavage 
of the two proteins.27 Sequences coding for mStrawberry and its adjoining zipper were ligated 
sequentially between the EcoRI, NotI and XbaI restriction sites of a pcDNA4/TO vector (Thermo 
Fisher Scientific, Waltham MA, U.S.A.) using T4 ligase (New England Biolabs, Ipswitch MA, U.S.A.). 
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Parallel, the sfGFP, zipper and P2A sequences were assembled into a single sequence using over-
lap-extension PCR, ligated into a pCR4-TOPO plasmid (Thermo Fisher Scientific, Waltham MA, 
U.S.A.) using the TA overlap, multiplied and digested using HindIII and EcoRI restriction enzymes 
(New England Biolabs, Ipswitch MA, U.S.A.) for subsequent ligation between the matching 
restriction sites of the pcDNA4 vector, already containing mStrawberry and its fused zipper 
sequence (Figure 6.11 and 6.12). Non-paired constructs were made by ligation into pcDNA4 con-
taining only mStrawberry. Linker-paired constructs were produced by site-directed mutagene-
sis of the C-terminal Pro-Gly-Pro sequence of the P2A peptide into Ala-Ala-Pro, removing the 
proline-glycine cleavage site. All 6 final plasmids were used to transform E. coli TOP 10 cells 
for multiplication and purified using a Qiagen Plasmid Midi kit. Confirmation of the constructs 
using sequencing revealed a single point-mutation at the N-terminal end of the P2A peptide 
(G3E) for the zipper-paired and unpaired constructs containing WoolA/B zippers. Although P2A 
cleavage occurs at the C-terminus, this could affect cleavage efficiency.
Expression of FRET constructs
Flp-In T-REx 293 cells (Thermo Fisher Scientific, Waltham MA, U.S.A.) were maintained in DMEM 
containing 10 % FCS and 100 IU/mL penicillin and 100 µg/mL streptavidin as well as 100 µg/mL 
zeocin and 15 µg/mL blasticidin during initial cell growth. Cells were passaged every 3-4 days. In 
preparation for expression, cells were transfected with 1 µg of the constructed plasmids using 
TransIT-LT1 transfection reagent (Mirus Bio, Madison WI, U.S.A.). After 24 hours, expression was 
induced by addition of 1 µg/mL doxycycline. After 24 hours of expression, cells were harvested 
for western blot analysis, spun down 5 min at 100 g, washed with PBS and suspended for 30 
min in lysis buffer (50 mM Tris pH 7.6, 100 mM KCl, 1 mM dithiothreitol, 1 mM ethylenediamine-
tetraacetic acid, 0.1 %(v/v) NP-40). Subsequently, cells were sonicated 5 times 30 s, debris was 
spun down and the supernatant was collected and stored at -20 ˚C. Expression was analysed by 
separation of the lysate on 15 % SDS-PAGE gel and subsequent western blotting. Expressed pro-
teins were detected using Living Colors JL-8 mouse anti-GFP (Clontech Laboratories, Mountain 
View CA, U.S.A.) and rabbit anti-RFP primary antibodies (Rockland Immunochemicals 600-401-
379, Limerick PA, U.S.A.), dissolved 1:3000-5000 in PBS containing 5 % non-fat dry milk and 
0.05% Tween-20. IRDye 800 goat anti-mouse and IRDye 680 goat anti-rabbit secondary antibod-
ies (LI-COR Biosciences, Lincoln NE, U.S.A.) were visualized in an Odyssey CLx infrared imaging 
scanner.
For microscopy analysis, cells were fixed instead of harvested using 3.7 % (v/v) formaldehyde and 
0.1 % Tween-20 in PBS for 30 min. Cell nuclei were stained for 5 min with 4’,6-diamidino-2-phe-
nylindole (DAPI) and mounted on glass slides with Mowiol solution. Slides were washed three 
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times with PBS and stored at 4 ˚C. Cells were kept in dark conditions during all steps. Imaging 
was performed at 37 ˚C on a Leica TCS SP8 confocal laser scanning microscope with white light 
laser and two-channel PicoQuant detectors and final images were obtained using FIJI.
6.3. Results and Discussion
Cell uptake of coiled-coil activated CPPs
In order to study the activity of coiled-coil activated CPPs with a protein cargo, the 
octa-arginine CPP was split in half and attached to one of the two strands of a leu-
cine zipper pair. While inactive in its split state, upon dimerization of the leucine 
zipper, the CPP is reconstituted and can internalize the attached protein cargo. To 
obtain optimal interaction, the strongly heterodimerizing leucine zipper pair VinA 
and VinB was used, first reported by Moll et al.28 Superfolder GFP (sfGFP)21 was linked 
to this R4-VinA sequence with either a cysteine or an alanine (R4-VinA-sfGFP and 
C->AR4-VinA-sfGFP), was expressed in bacteria and purified. The complementary 
leucine zipper needed to form the Vin coiled-coil was the peptide Ac-RRRRCGGGG-
VinB (Ac-R4-VinB). It was expected that R4-VinA-sfGFP, and if a disulfide bridge is not 
needed also C->A-R4-VinA-sfGFP, would be taken up only after coiled-coil forma-
tion with Ac-R4-VinB. First, HeLa cells were incubated with 5 μM R4-VinA-sfGFP or 
C->A-R4-VinA-sfGFP for 90 min at 37 °C. As expected, we did not observe any uptake. 
However, when repeated with addition of 5 μM Ac-R4-VinB, both R4-VinA-sfGFP and 
C->A-R4-VinA-sfGFP were internalized (Figure 6.3). These results show that reconsti-
tution of the split CCP allows the internalisation of a large cargo. The coiled-coil-me-
diated CPP of the Vin-zipper is efficient without the need for a disulfide bridge. The 
cellular-localized sfGFP showed a punctuate green fluorescence pattern, suggesting 
that the protein complexes were taken up by endocytosis, which is common for CPPs 
with larger cargo.29,30
Instead of sfGFP, we also tested whether mStrawberry22 can be internalized by recon-
stitution of the split CCP. After expression and purification, R4-VinA-mStrawberry and 
C->A-R4-VinA-mStrawberry were incubated with HeLa cells. As expected, no uptake 
was observed. However, repeated with addition of the complementary R4-VinB, it 
triggered rapid cell death. This result was unexpected, as mStrawberry is structurally 
similar to sfGFP and is generally considered to have low toxicity and therefore often 
used in live-cell-imaging.31,32 It is possible that a fraction of the mStrawberry after 
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endocytosis ends up in acidic lysosomes, which may increase its phototoxicity. Red 
fluorescent proteins have been reported to have a higher phototoxicity than other 
fluorescent proteins, due to their production of reactive oxygen species.33 Although 
this effect is reportedly not high for mRFP-based variants like mStrawberry, this has 
not been tested in the acidic environment of the lysosome. If this is the case, the fact 
that the toxicity is only seen after addition of the R4-VinB peptide, makes it likely that 
also mStrawberry can be internalized in HeLa cells by reconstitution of the split CCP. 
Alternatively, the structural differences between sfGFP and mStrawberry could be 
large enough to cause a disruption of the cell membrane by the latter during inter-
nalisation. This would be consistent with the rapid progress of cell death observed.
Intracellular leucine zipper dimerization
To assess whether leucine zippers could also be used for creating intracellular pro-
tein complexes, three different DNA constructs were made that encode fusion pro-
teins for which dimerization can be tracked by FRET. A construct encoding sfGFP 
fused to the VinA zipper as well as mStrawberry fused to VinB was generated. Both 
proteins were separated by a P2A peptide, which results in spontaneous cleavage 
between these two fluorescent proteins upon translation (Figure 6.2).27 As a result of 
the monocistronic production strategy the sfGFP-VinA and mStrawberry-VinB pro-
teins are produced in equal amounts, eliminating possible variations due to differ-
ences in expression levels. Because energy transfer through FRET depends highly 
on inter-fluorophore distance, the split proteins were expected to show no FRET, 
unless leucine zipper-mediated dimerization of the two proteins would increase 
energy transfer, yielding higher red fluorescence upon excitation of the sfGFP. As 
controls an unpaired variant, missing one of the leucine zipper-peptides, and a 
linker-paired variant, whereby the two fluorescent proteins were not separated due 
Figure 6.3: Cellular uptake of sfGFP by leucine-zipper activated CPPs. Confocal microscopy images of 
uptake experiments in HeLa cells of a Vin zipper modified sfGFP either containing a cysteine (middle) 
or an alanine (right) with and without a complementary peptide (left) a complementary zipper pep-
tide. Scale bar represents 50 µm.
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to an inactivated P2A sequence, were generated. Additionally, similar constructs 
were generated with the more recently developed WoolA/WoolB leucine zipper pair, 
which is about 10 amino acids shorter than the VinA/VinB pair, while retaining a 
similar strong interaction.26
Western blot analysis of lysates from HEK293 cells expressing these constructs are 
depicted in Figure 6.4. The VinA/VinB fusion proteins were expressed and split when 
the functional P2A peptide was present, resulting in sfGFP-VinA (green) and mStraw-
berry-VinB (red). The small size difference of the two proteins is likely due to the 
presence of the cleaved P2A peptide at the C-terminus of sfGFP-VinA. In the unpaired 
situation, mStrawberry migrated faster due to the absence of the VinB peptide and 
in the linker-paired situation, the protein construct remains uncleaved, yielding a 67 
kDa band that is detected by both antibodies. The corresponding proteins with the 
WoolA/B zipper showed similar features, although in this case the P2A peptide was 
incompletely cleaved, most likely caused by a G3E mutation unintentionally intro-
duced at the N-terminal end of this peptide. Additionally, an unidentified polypeptide 
of around 45 kDa was observed, which was only recognized by the anti-GFP antibody 
and thus likely is a breakdown product containing a partial mStrawberry polypep-
tide, together with an mStrawberry-band at 35 kDa for the linker-paired protein.
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Figure 6.4: Western blot analysis of expression in HEK293 cells. a) lysates of FRET constructs with 
the VinA/B zipper pair and b) lysates of FRET constructs with the WoolA/B zipper pair. Indicated are 
cultures with and without doxycycline for induction of the expression. Fluorescence of the secondary 
antibody dye at 800 nm (green, anti-GFP) and 700 nm (red, anti-mStrawberry) are overlayed, resulting 
in orange/yellow colouring for overlapping bands and size is indicated by a dual colour pre-stained 
marker. * indicates an unidentified fragment.
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Fluorescence microscopy confirmed the expression of sfGFP and mStrawberry con-
structs in transfected HEK293 cells (Figure 6.5 and 6.6). For each of the constructs 
the proximity of sfGFP and mStrawberry was assessed by FRET analysis. Although 
the level of energy transfer observed was relatively small for all constructs, for 
both the VinA/B and WoolA/B zipper-paired constructs elevated FRET levels were 
observed compared to the unpaired constructs (Figure 6.5 and 6.6, FRET panels). For 
the WoolA/B pair, the FRET levels were comparable to the linker-paired controls. 
Unexpectedly, the linker-paired VinA/B positive control did not show elevated FRET, 
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Figure 6.5: VinA/B leucine zipper mediated FRET imaged by confocal laser scanning microscopy. 
Depicted are confocal images of sfGFP and mStrawberry with unpaired zipper (negative control), 
zipper-paired, and linker-paired (positive control) in fixed HEK293 cells. sfGFP is imaged by excitation 
at 485 nm and imaging at 510 nm, mStrawberry by excitation at 574 nm and imaging at 596 nm. The 
FRET signal is the emission at 596 nm during excitation at 485 nm. Scale bars indicate 40 µm.
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the clear presence of elevated FRET for the zipper-paired constructs suggests FRET 
efficiency is reduced due to the linker. Combined, these results indicate that these 
leucine zippers can be used to mediate the interaction between two proteins in cells. 
Elevated FRET levels were substantiated by comparison of the emission spectra of 
the zipper-paired and unpaired constructs at single cell level. Images were taken 
every 10 nm at wavelengths between 500 and 640 nm and the intensities of the flu-
orescent signals were quantified (Figure 6.7a). The zipper-paired proteins showed a 
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Figure 6.6: WoolA/B leucine zipper mediated FRET imaged by confocal laser scanning microscopy. 
Depicted are confocal images of sfGFP and mStrawberry with unpaired zipper (negative control), 
zipper-paired, and linker-paired (positive control) in fixed HEK293 cells. sfGFP is imaged by excitation 
at 485 nm and imaging at 510 nm, mStrawberry by excitation at 574 nm and imaging at 596 nm. The 
FRET signal is the emission at 596 nm during excitation at 485 nm. Scale bars indicate 40 µm.
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peak for mStrawberry emission at 596 nm that was not present in cells expressing 
the unpaired proteins. Next, to assure that this 596 nm emission was indeed due 
to FRET, the cells were briefly exposed to a high intensity 574 nm laser, leading to 
bleaching of the mStrawberry fluorophore. Bleaching reduced mStrawberry emis-
sion and increased sfGFP emission due to the reduced energy transfer (Figure 6.7b). 
This result supports that the emission peak at 596 nm is due to FRET, resulting from 
the proximity of zipper-paired sfGFP and mStrawberry.
Remarkably, the VinA/B leucine zipper-mediated interaction of sfGFP and mStraw-
berry appeared to affect their subcellular localisation, since the zipper-paired signal 
was most pronounced in the cytoplasm, while the fluorescent signals of the unpaired 
proteins were present in the entire cell (see Figure 6.8). The most likely explanation 
for these observations is that the size of the heterodimer prevents or diminishes 
nuclear import. 
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Figure 6.7: Confirmation of FRET by spectral analysis and acceptor photobleaching. a) The averaged 
emission spectra of cells containing either zipper-paired and unpaired VinA/B constructs (marked 
with a white circle), upon excitation of the sfGFP with 485 nm. Emission spectra are normalized at 
510 nm. b) Comparison of the intensity of sfGFP and mStrawberry fluorescence during 10 s before 
and 30 s after acceptor photobleaching. Displayed is the 510 and 596 nm emission of the linker-paired 
WoolA/B construct upon excitation with 485 nm light.
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Although results show a zipper-mediated dimerization, quantification of this 
dimerization proved unreliable due to the relatively low FRET levels, even for the 
linker-paired constructs. In retrospect, sfGFP and mStrawberry were maybe not the 
best suitable combination as FRET pair. Although sfGFP emission and mStrawberry 
absorption spectra have a decent overlap (Figure 6.9), enabling energy transfer, 
they are not a well characterised FRET pair. Additionally, the orientation of the flu-
orophores upon zipper-mediated dimerization might be suboptimal leading to an 
inefficient energy transfer, similar to the linker-paired VinA/VinB construct which, 
although physically linked to each other, only showed a low FRET signal (Figure 6.5, 
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Figure 6.8: Subcellular localisation of unpaired (left) and zipper-paired (right) VinA/B constructs. 
Depicted is a crop of a confocal laser scanning microscopy image with a single HEK293 cell. The 
image of the zipper-paired construct shows a ‘hole’ in the cell, probably due to reduced nuclear 
localisation. sfGFP is imaged by excitation at 485 nm and imaging at 510 nm, the FRET signal is the 
emission at 596 nm.
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Figure 6.9: Absorption and emission spectra of EGFP (highly similar to sfGFP21) and mStrawberry.35 
The spectral overlap between donor (EGFP) emission and acceptor (mStrawberry) absorption, rele-
vant for FRET, is marked in yellow.
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lower FRET panel). To improve this, a spacer might be added between the zipper 
peptides and fluorescent proteins to either increase the flexibility or adjust the ori-
entation of the fluorophore. 
Molecular tools to control well-defined protein complexation, such as demonstrated 
here by leucine zipper-mediated interactions, can also be used for manipulating 
or mimicking natural signalling systems, which often rely on assembly and disas-
sembly of protein complexes. The combination of intra- and extracellular leucine 
zippers might for example be used to trigger disassembly of a complex of two or 
more tagged proteins by the addition of a competing leucine zipper peptide, which 
is internalized by a regulated CPP. Alternatively, photoactivatable leucine zippers34 
would allow switchable assembly and disassembly of protein complexes with a high 
temporal resolution.
6.4. Conclusions
Taken together, we have shown that leucine zippers can be used to achieve control 
over interactions between proteins and peptides in a cellular context. First, split 
CPPs can be activated by leucine zipper coiled coil formation leading to the recon-
stitution of an active octa-arginine CPP. The activated CPPs can initiate internaliza-
tion of a cargo protein through endocytosis. Second, intracellular protein complexes 
can be generated by their fusion to leucine zippers, as demonstrated by means of 
two fluorescent proteins which exhibit an increase in FRET upon zipper-mediated 
dimerization. 
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6.6. Supplementary Figures
Figure 6.10: Vector map of the plasmid encoding for the R4-VinA-sfGFP construct.
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Figure 6.11: Vector map of the plasmid encoding for the zipper-paired VinA/B construct.
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Figure 6.12: Vector map of the plasmid encoding for the zipper-paired WoolA/B construct.
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Figure 6.13: Purification of C->A-R4-VinA-sfGFP and R4-VinA-sfGFP (theoretical both 42 kDa) using 
immobilized metal affinity chromatography. pel: pellet, sup: supernatant, ft: flow through, elutions: 50 
mM imidazole, 2nd elutions: 500 mM imidazole.
Table 6.1: Oligonucleotide sequences for PCR primers and synthetic P2A-peptide sequence.
Primer Sequence
C->A-R4-VinA-fw: CGAGGGCCGCGCTCGTCGCCGACGTTTGGAAATT 
GAAGCAGCC
C->A-R4-VinA-rev: GCGGCCCTCGATCTCGAGGTGATGGTGATG
HindIII-sfGFP-fw: AAGCTT GCCACC ATGAGCAAAGGAGAAGAAC 
sfGFP-KpnI-rev: GGTACC TTTGTAGAGCTCATCCATG 
GFPKpn-ER-fw: GCTCTACAAAGGTACC TTGGAAATTGAAGCAGC 
ER-p2ABam-rev: GCTTCCGGATCC TAATGGACCATAGCGAG 
EcoI-Straw-fw: CTGGACCTGAATTC ATGGTGAGCAAGGGC 
Straw-Not-rev: GGCGGCCGC CTTGTACAGCTCGTCCATG 
Not-RE-fw: GCGGCCGCC CTTGAAATTCGGGCAG 
RE-Xba-rev: GATTCTAGA TAAAGGTCCATACCGCG 
GFPKpn-WA-fw: GCTCTACAAAGGTACC GGGGAAATCGCCG 
WA-p2ABam-rev: GCTTCCGGATCC TTGTTCAAGAGCAGCTATCTC 
Not-WB-fw: GATTCTAGA ACCGCCCTGCTTAAGAG 
WB-Xba-rev: GCGGCCGCC GGCAAAATTGCCGC 
P2A-fw: GGATCCGGAAGCG 
MutantP2A-rev: GAATTCAGGTGCAGC GTTCTCCTCCACGTCTC 
P2A-EcoRI-rev: CATGAATTCAGGTCCAGGG 
P2A-sense: GATCCGGAAGCGGAGCTACTAACTTCAGCCTGCTGAAGC 
AGGCTGGAGACGTGGAGGAGAACCCTGGACCTGAATTC 
P2A-antisense: GAATTCAGGTCCAGGGTTCTCCTCCACGTCTCCAGCCTGCTT 
CAGCAGGCTGAAGTTAGTAGCTCCGCTTCCGGATCC 
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Dan alle boecken gelesen hebbende, ende alle meesters gehoret, daer blijft 
 noch sooveel te bedencken, dat men den iver niet sal missen.
When all books are read and all masters are heard, there remains so 
much to think about, that the diligence shall not be missed.
Isaac Beeckman, inventor, philosopher and scientist 
Journal, 1617
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With the growth of biomolecular interaction analysis over the years, a lot of attention has been focussed on technical developments. Not without 
reason, the possibilities of ever smaller biosensors capture the imagination and mod-
ern automation allows analyses with throughputs that would have been unfathoma-
ble before. Nevertheless, all these techniques have to cope with some common issues. 
Talk with almost any scientist working on biomolecular interaction analysis, and 
non-specific binding, protein stability, carry-over or immobilization techniques will 
quickly be a topic of discussion. Not in the least because typically each interaction 
requires tuning of analysis conditions and methodology to get the best results. With 
modern multiplex techniques, these issues become even more pronounced, as the 
high throughput and variety of interactions analysed with these techniques require 
even more optimisation work. In this thesis therefore we started with the develop-
ment of techniques adapted to such multiplex, high throughput equipment, which 
provide new options to avoid some of these issues.
In Chapter 2 a novel technique for optimization of regeneration conditions is 
described. This technique uses the benefits of multiplex technology not to improve 
analysis, but instead to speed up optimization of the analysis procedures by multi-
plexing the forced dissociation of a bound analyte to regenerate a sensor surface, 
in order to enable multiple subsequent analyses. Such scaled optimization of con-
ditions gives scientists a broad overview of the effects of various parameters. The 
augmented information set not only allows a faster determination of optimal condi-
tions, but also facilitates the simultaneous optimization for the different interactions 
taking place in a multiplex assay. As a result, interaction studies can be performed 
in a more time-efficient fashion and save costs due to the easier re-use of sensor 
surfaces.
In Chapter 3 we focused on the immobilization of biomolecules. For many types of 
biosensors, this is a crucial step that strongly influences measurement outcomes as 
well as assay conditions. For example, immobilization based on strong interactions 
usually allows a wider range of possible regeneration conditions. The use of leu-
cine zipper peptide tags to establish a strong and specific bond, provides a modular 
method to immobilization of proteins. Using orthogonal leucine zippers, the system 
can easily be adapted to allow immobilization of a set of proteins at specific places 
on a sensor. This can be achieved by printing leucine zippers at the desired places of 
a sensor and subsequent incubation with orthogonal leucine zipper-tagged proteins. 
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Such a two-step system has the advantage that only peptides, which are typically 
much easier to handle than proteins due to the better stability and reduced chemi-
cal complexity, need to be printed on the surface. This could also be useful in other 
applications than biosensors, for example many biomaterials are now also incorpo-
rating immobilized proteins to provide functionality, which could certainly benefit 
from tighter control over orientation and localisation. 
The method for determination of antibody levels in serum, described in Chapter 4, 
mainly focussed on the application of the multiplex technique, but also addressed 
a similar immobilization problem. The equilibrium responses needed to determine 
the antibody levels were inconsistent and varied considerably with different SPR 
chips and immobilisation densities. Since the immobilized ligands in these exper-
iments were peptides and the low concentration of certain antibodies required a 
high peptide density, there were limited options to improve immobilization further. 
As an alternative, the analysis method was adapted. By changing the analysis method 
to one based on binding rates, variation in immobilization densities became a less 
important factor in the results, and more reproducible and reliable antibody lev-
els could be determined. In addition, this analysis method was also less affected by 
different antibody affinities, giving better results for a complex antibody mixture. 
Nevertheless, even with these improvements still a degree of variation was pres-
ent, which shows that the natural complexity of sera remains a challenge for SPR 
technology.
The benefit of a well-controlled immobilization method became clear in Chapter 
5. While the binding behaviour of the small heat-shock protein αB-crystallin in a 
multi-subunit complex had been studied before, it was in those studies impossible 
to account for the complex dynamics involved. Even though our results were not 
quite conclusive, the analysis of the binding behaviour of αB-crystallin in a dynamic 
complex would not have been possible without specific immobilization techniques. 
Though, in this case our method involving a surface covered with rather hydropho-
bic, unstructured leucine zippers, which resemble a typical substrate for small heat-
shock proteins might not have been the best choice. This also once again confirms 
the importance of the choice of a protein immobilization method, and great care 
should be taken with selection of these, as different applications result in different 
trade-offs. 
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Chapter 6 is an example of the versatility of leucine zipper peptide tags in other 
applications than immobilisation for biomolecular analysis. The property of a bio-
logical tag that can bring two proteins together creates new possibilities by using 
this as a switch that allows controlled combination and triggering of functionality. 
In this case, a switchable cell-penetrating peptide was designed.  One peptide is used 
as a trigger, potentially with a targeting element. A second one carries a cargo. Only 
the combination of the cargo and the trigger will activate the cell penetrating pep-
tide. Since this is a system composed entirely of biomolecules, it can be constructed 
intracellularly. This could allow new applications inside the cell. An intracellular leu-
cine zipper combined with an external trigger, like a cell-penetrating peptide or a 
photo-activated leucine zipper, could trigger or disable cellular processes by bring-
ing two intracellular proteins together.
The techniques presented in this thesis add a new set of tools to the toolbox for bio-
molecular interaction analysis, especially for multiplex technologies. A toolbox that 
deserves more attention, as the analysis of biomolecular interactions relies consid-
erably on experience with experimental conditions and interpretation of the data. 
Unlike other high-tech techniques such as mass spectrometry, which has evolved to 
a routine analysis method with rather binary outcomes, interaction analyses often 
lack robustness and can easily give misleading results if experimental conditions and 
methods are not properly controlled. This is especially a problem for applications like 
diagnostics or quality control, where proper validation and well-defined error mar-
gins are a requirement. In scientific literature this is further compounded by modern 
software that has user-friendly one-click-fit buttons, resulting in a nice set of num-
bers. But judging the applicability of a certain model, or the quality of a fit remains 
up to the user.  Furthermore, a common criticism often heard is that “the biosensor 
experiments could have been done better.” Therefore, we should further expand the 
toolbox with more robust methods and advertise these new tools to entice scientists 
to use these by default. Instead of first trying to get away with a ‘simple’ measure-
ment, which subsequently requires a critical review to see if it is actually correct, 
ideally a set of techniques (such as non-fouling surfaces, well-defined immobiliza-
tion chemistry and confirmed regeneration) should be available. This should come 
with clear selection criteria, be appropriate for a large set of applications and should 
provide equipment software which could immediately test for this appropriateness. 
Our immobilization strategy using leucine zipper peptide tags is a first step towards 
such a system: it is designed to provide a choice of antifouling peptides to minimize 
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non-specific binding under various conditions and it can use different leucine zip-
pers with specific binding properties. However, as we have seen in Chapter 5, there 
is still room for improvement, for example by shielding the leucine zippers when not 
in use. In the meantime, we should all try to avoid common pitfalls in our experimen-
tal design and critically review acquired data to see if underlying assumptions hold 
and the data make sense.
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Biomolecules, such as lipids and proteins, make up the molecular basis of a cell. For 
the cell to function, these molecules move and interact continuously. Disturbances 
of these interactions are the cause of various disease processes, which makes the 
analysis of biomolecular interactions a crucial part of biomedical research and med-
ical diagnosis. This thesis describes our efforts to improve the analysis of biomolecu-
lar interactions and its applications.
Chapter 1 introduces the use of tags to immobilise biomolecules, typically proteins, 
on a biosensor to analyse the interaction between these immobilised biomolecules 
and the molecules present in the solution to be analysed, called the analyte. An 
important technology for such interaction analysis is surface plasmon resonance 
(SPR). In SPR, binding of molecules to the sensor surface can be monitored in real 
time through changes in the reflection of a light bundle at the sensor surface. The 
immobilisation of proteins on such a sensor is typically achieved by non-specific 
coupling chemistry, leading to random orientations of the molecules. A better con-
trol of this immobilisation process may increase the sensitivity and reproducibility. 
To achieve this, specific chemical functionalities can be introduced in the protein 
that needs to be immobilised. One method to do so, is to attach a peptide tag which 
can be specifically bound by a functionality already present on the biosensor surface. 
Several forms of such peptide tags are discussed. For this thesis the most important 
tag is the leucine zipper. The leucine zipper consists of two tightly interacting coiled 
helices, with a string of hydrophobic leucines at the interface, interleaved with neg-
atively or positively charged amino acids. These two complementary leucine zipper 
peptides act like a zipper, hence the name. In this way, molecules can be attached 
to the sensor’s surface in a controlled way, resulting in the same orientation of all 
molecules with respect to the surface. Subsequently, the biosensor can be used to 
detect binding partners in the solution to be analysed.
After completion of a biosensor analysis, breaking the binding of the interacting part-
ner molecules would allow the sensor to be used for another analysis, and therefore 
regeneration of the sensor surface should be very efficient. During regeneration, the 
analyte needs to be removed from the biosensor, without destroying the binding 
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properties of the immobilised biomolecules. The optimal conditions to achieve this 
can be very different for different biomolecules, which makes determination of the 
most suitable conditions a time-consuming process. Chapter 2 describes a method 
to test multiple conditions simultaneously using a microspotter, by regenerating a 
series of spots on the sensor surface in parallel. The efficiency of the regeneration 
under the selected conditions was assessed by analysing the binding of an analyte 
using surface plasmon resonance imaging. By repeating the regeneration several 
times, it became clear whether or not the binding properties of immobilised bio-
molecules were affected. This way we could show that using a combination of a 
multiplex microspotter and SPR equipment a faster optimisation of the regeneration 
conditions can be obtained.
Chapter 3 describes the development of an integrated method for site-specific 
immobilisation of proteins on a biosensor surface. The gold surface of a biosensor 
was coated with an anti-fouling layer of short zwitterionic peptide molecules from 
which longer leucine zipper peptide molecules protrude. Proteins of interest fused 
to the complementary leucine zipper sequence as a binding tag were immobilized 
via a simple incubation procedure. Visualization of the immobilized proteins of inter-
est by SPR demonstrated 2.5 times higher binding responses than when these pro-
teins were randomly attached. The proteins could also be immobilized in a leucine 
zipper-dependent manner directly from bacterial lysates, eliminating the need for 
laborious purification steps. This method allows the production of uniform func-
tional protein arrays by control over immobilized protein orientation and geometry 
and is compatible with high-throughput procedures.
One of the applications where multiplex SPR sensors are used is screening of patient 
sera for the presence of anti-citrullinated protein antibodies (ACPA). Citrullination 
occurs as a post-translational modification (PTM) and involves the conversion of a 
positively charged arginine into an uncharged citrulline. The presence of the anti-
bodies against proteins containing this modification aids the diagnosis and disease 
management of rheumatoid arthritis (RA). The specificity of ACPA can vary and some 
variants are targeted only to specific citrullinated peptides. By profiling the sub-spe-
cificities of ACPA, putative relations between different citrullinated peptides and dis-
ease development and progression might be revealed. In Chapter 4 the reactivity of 
ACPA with 43 citrullinated peptides and an optimised analysis method are described. 
The method was developed to determine the presence of antibodies based on 
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binding kinetics under mass transport limited conditions. Under these conditions 
the influence of variations in the amount of immobilized peptides and the affinities 
of antibodies is minimalised. This new analysis method improved the reproducibility 
and enhanced the efficiency.
In Chapter 5, the SPR technology was used to investigate the oligomeric complex 
formation of small heat-shock proteins. Small heat-shock proteins act as chaper-
ones: they stabilise and refold other proteins. For the most studied member of this 
family, αB-crystallin, the dynamic behaviour of sub-units entering and leaving the 
complex appears to be related to its chaperone activity. This dynamic behaviour 
differs at high and low pH values, which reflects a mechanism triggered by acidifi-
cation. To further characterize αB-crystallin complex dynamics, we have developed 
a model based on previous studies on the distribution of the number of subunits in 
a complex. Our model describes the binding behaviour of these complexes to single 
subunits immobilized by a leucine zipper on the surface of a SPR chip. Although our 
experimental results showed relatively low binding levels, which impedes quantita-
tive analyses, they indicated pH-sensitive dynamics in agreement with the proposed 
binding model and the previously reported binding behaviour.
Leucine zippers can be useful for other applications, as, for example, demonstrated in 
Chapter 6. The combination of multiple functionalities in supramolecular complexes 
might create new functionalities and is key to many biological systems. Leucine zip-
pers represent a promising protein domein for the design of such protein complexes 
by acting as modular linkers between proteins within a complex. In this chapter we 
investigated the use of leucine zippers as modular linkers, both in the extracellu-
lar and intracellular environments. Extracellularly, we used leucine zippers to trig-
ger cellular import of a protein cargo by activating a cell-penetrating peptide. This 
type of inducible import can be highly useful for targeted drug delivery applications. 
Intracellularly, we showed the feasibility of using engineered leucine zippers to cre-
ate self-assembled complexes by monitoring the leucine zipper-mediated dimeri-
zation of fluorescent proteins by means of Förster Resonance Energy Transfer. The 
controlled complex formation in cells might be useful for future manipulation of 
intracellular processes.
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The developments described in this thesis provide new additions to the toolbox for 
biomolecular interaction analysis. As described in Chapter 7, this toolbox can still 
use more additions, especially those that are robust and widely applicable. Ideally, 
new methods should come with clear selection criteria that allow easy testing of 
their applicability. 
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Biomoleculen, zoals lipiden en eiwitten, vormen de moleculaire basis waaruit een 
cel is opgebouwd. Continu bewegen en interacteren deze met elkaar om een cel 
goed te laten functioneren. Verstoring van dit soort interacties ligt aan de basis van 
verscheidene ziekteprocessen. Daarom is het analyseren van de interacties tussen 
biomoleculen een belangrijk onderdeel van biomedisch onderzoek en medische 
diagnoses. In dit proefschrift zijn onze bijdragen aan verbetering van dit soort 
analyses en een aantal toepassingen ervan beschreven.
Hoofdstuk 1 introduceert het gebruik van labels om biomoleculen, meestal 
eiwitten, vast te zetten op biosensoren. Deze biosensoren kunnen vervolgens de 
interacties tussen deze vastzittende biomoleculen en moleculen in een vloeistof 
meten. Een belangrijke techniek voor het meten van interacties in een biosensor 
is surface plasmon resonance (SPR). Hiermee kan binding aan moleculen op het 
sensoroppervlak direct worden gevolgd door een verandering in de reflectie van 
een lichtbundel op het sensoroppervlak te meten. Het immobiliseren van eiwitten op 
zulke biosensoren gebeurt vaak via aspecifieke chemische koppelingen, waardoor 
de eiwitten in willekeurige oriëntatie op de sensor komen te zitten. Door dit beter 
te controleren kan de gevoeligheid en reproduceerbaarheid van een sensor worden 
verbeterd. Hiervoor kunnen specifieke chemische groepen in het eiwit worden 
gebruikt of ingebouwd. Één vorm hiervan is het aanbrengen van een ‘peptide tag’, 
een stukje eiwit dat specifiek gebonden kan worden door een molecuul op het 
oppervlak van de biosensor. Verschillende vormen hiervan worden besproken. 
Voor dit proefschrift is de belangrijkste peptide tag de leucine zipper, die bestaat 
uit twee om elkaar wikkelende helices, met daartussen het hydrofobe aminozuur 
leucine, afgewisseld met negatief of positief geladen aminozuren. Deze vormen als 
het ware de tanden van een ritssluiting, vandaar de naam zipper. Op deze manier 
kunnen moleculen op een gecontroleerde wijze vastgezet worden op het oppervlak 
van een biosensor, waarbij ze allemaal een zelfde oriëntatie aannemen ten opzichte 
van het oppervlak. Vervolgens kan de biosensor gebruikt worden voor de detectie 
van bindingspartners in een te analyseren vloeistof.
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Nadat er een analyse op een biosensor is gedaan, is het gebruikelijk om de 
binding tussen de twee interactiepartners weer te verbreken, zodat het sensoroppervlak 
geregenereerd wordt voor een volgende analyse. Bij dit proces moeten de gebonden 
moleculen efficiënt verwijderd worden, maar zonder dat de sensormoleculen 
op het oppervlak aangetast worden. De condities waaronder dit gebeurd kunnen 
sterk verschillen voor verschillende interactiepartners, waardoor het vinden 
van de goede conditie een tijdrovend proces kan zijn. Hoofdstuk 2 beschrijft een 
methode waarbij een microspotter werd gebruikt om meerdere condities 
tegelijkertijd te beoordelen door kleine delen van het oppervlak tegelijkertijd met 
verschillende oplossingen te regenereren. De efficiëntie van regeneratie werd 
bepaald door vervolgens dezelfde binding opnieuw te analyseren met behulp van 
SPR imaging. Door dit proces van binding en regeneratie te herhalen, kon worden 
achterhaald of de sensormoleculen op het oppervlak intact bleven. Zo bleek dat met 
de combinatie van een multiplex microspotter en SPR apparaat een veel snellere 
optimalisatie gedaan kon worden. 
In Hoofdstuk 3 wordt de ontwikkeling van een geïntegreerde methode beschreven 
om eiwitten specifiek op het oppervlak van een biosensor te plaatsen. Hierbij werd het 
gouden sensoroppervlak bedekt met een afstotende laag van korte, zwitterionische 
peptiden, waarvan een deel voorzien is van leucine zippers die boven de afstotende 
laag uitsteken. Door de te immobiliseren eiwitten uit te rusten met een bijpassend, 
complementair leucine zipper domein, konden deze met een simpele incubatiestap 
geïmmobiliseerd worden op het oppervlak. Detectie van de geïmmobiliseerde 
eiwitten door middel van SPR liet een 2,5 maal hoger signaal zien dan wanneer 
de eiwitten willekeurig geïmmobiliseerd werden. Ook konden deze gelabelde 
eiwitten direct worden geïmmobiliseerd uit complexe oplossingen zoals bacterie-
lysaat, waardoor minder zuiveringsstappen nodig zijn. Deze methode maakt het 
mogelijk om uniforme eiwitsensoren te produceren, door betere controle over de 
eiwitoriëntatie, en is geschikt voor toepassingen die een hoge doorstroomcapaciteit 
vereisen.
Een van de toepassingen van multiplex SPR sensoren is het screenen van patiëntensera 
voor de aanwezigheid van anti-citrullinated protein antibodies (ACPA). Citrullinering 
is een eiwitmodificatie waarbij het ‘normale’, positief geladen aminozuur arginine 
wordt omgezet in het ongeladen citrulline. De detectie van antilichamen tegen 
deze specifieke eiwitmodificatie wordt veel gebruikt bij de diagnose en het volgen 
samenvatting | 133
van het beloop van de ziekte reumatoïde artritis. De specificiteit van ACPA kan 
sterk variëren en kan gericht zijn op één of meerdere gecitrullineerde eiwitten. 
Door deze verschillen in ACPA te karakteriseren kan mogelijk een relatie tussen de 
herkende gecitrullineerde eiwitten en ziektestadia en het ziekteverloop worden 
gelegd. In Hoofdstuk 4 rapporteren we de reactiviteit tegen 43 gecitrullineerde 
eiwitten en een nieuwe, geoptimaliseerde analysemethode. Bij deze methode 
wordt antilichaamreactiviteit bepaald op basis van de bindingskinetiek onder 
massatransport-gelimiteerde condities. In deze situatie is de invloed van variatie 
in de hoeveelheid geïmmobiliseerde peptiden en antilichaamaffiniteiten minimaal. 
Daarmee werd een betere reproduceerbaarheid en kortere analysetijd bereikt.
In Hoofdstuk 5 is de SPR technologie gebruikt om de vorming van oligomere 
complexen door kleine heatshock eiwitten te onderzoeken. Deze eiwitten werken 
als chaperonnes: ze stabiliseren of hervouwen andere eiwitten. Voor het meest 
bestudeerde lid van deze familie, αB-crystalline, lijkt het dynamisch gedrag van 
sub-eenheden die zich in en uit een complex bewegen samen te hangen met de 
chaperonneactiviteit. Dit gedrag verschilt tussen omstandigheden met hoge en lage 
zuurgraad, wat een indicatie kan zijn voor activering door verzuring. Om dit gedrag 
beter te begrijpen, is op basis van eerdere studies naar de veranderende verdeling 
van het aantal subeenheden in een complex een model opgesteld. Dit model beschrijft 
het bindingsgedrag van complexen aan een enkele subeenheid die via een leucine 
zipper op het oppervlak van een SPR chip geïmmobiliseerd is. Experimenten om dit 
model te ondersteunen resulteerden in lage bindingsniveaus, wat kwantitatieve 
analyses bemoeilijkte, maar wezen wel op een pH-afhankelijk bindingsgedrag, in 
overeenstemming met het model en de eerder gerapporteerde resultaten.
Dat leucine zippers nog andere toepassingen kunnen hebben wordt geïllustreerd 
in Hoofdstuk 6. Het combineren van verschillende functionaliteiten in een 
supramoleculair complex kan nieuwe functies in een eiwit creëren en is een 
belangrijk onderdeel van veel biologische systemen. Leucine zippers representeren 
een veelbelovend eiwitdomein om dit soort complexen mee te ontwerpen, door ze 
als verbindingsstuk te incorporeren. In dit hoofdstuk hebben we dit laten zien door 
leucine zippers als verbindingsstuk in te zetten, zowel buiten als binnen een cel. In 
het eerste geval zijn leucine zippers gebruikt om celopname van een eiwit gericht 
te induceren, door het activeren van een peptide dat door de cel opgenomen wordt. 
Deze gestuurde celopname kan gebruikt worden voor het doelgericht afleveren 
134 | samenvatting
van medicijnen in een bepaald type cel. Binnen de cel hebben we laten zien dat het 
mogelijk is om leucine zippers te gebruiken om zelf-assemblerende complexen te 
maken. Fluorescente eiwitten werden uitgerust met leucine zipper peptiden, zodat 
de dimerisatie te volgen was door middel van Förster Resonance Energy Transfer 
(FRET), dat zorgt voor een verandering in de fluorescentie als twee fluoroforen 
dicht bij elkaar komen. Een gecontroleerde dimerisatie kan in de toekomst wellicht 
gebruikt worden om intracellulaire processen te beïnvloeden.
Zo vormen de ontwikkelingen die in dit proefschrift zijn beschreven een nieuwe 
toevoeging aan de gereedschapskist voor analyse van biomoleculaire interacties. 
Een gereedschapskist die, zoals beschreven in Hoofdstuk 7, ook in de toekomst nog 
verder uitgebreid kan worden, vooral door ontwikkeling van robuuste methoden 
die breed toepasbaar zijn. Bij voorkeur worden deze nieuwe methoden ook uitgerust 
met duidelijke selectiecriteria, die beschrijven en het mogelijk maken om eenvoudig 
te testen, voor welke situaties een methode wel of niet geschikt is.
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